ࡱ> { >bjbj(( AHJfJfT1,,8 (. """"""$y/tFi F4 j  6,=YsL 0<8,,>\(=>>>FF>>> >>>>>>>>>,X :  HYPERLINK "http://www.ontario.ca/fr/lois/reglement/900682" Franais Laboratory and Specimen Collection Centre Licensing Act R.R.O. 1990, REGULATION 682 LABORATORIES Consolidation Period: From March 3, 2021 to the  HYPERLINK "http://www.e-laws.gov.on.ca/navigation?file=currencyDates&lang=en" e-Laws currency date. Last amendment:  HYPERLINK "https://www.ontario.ca/laws/regulation/R21158" 158/21. Legislative History: 404/91, 607/91, 525/92, 399/93, 417/93, 795/93, 206/96, 46/98, 352/98, 536/98, 551/99,  HYPERLINK "https://www.ontario.ca/laws/regulation/R00068" 68/00,  HYPERLINK "https://www.ontario.ca/laws/regulation/R00564" 564/00,  HYPERLINK "https://www.ontario.ca/laws/regulation/R01017" 17/01,  HYPERLINK "https://www.ontario.ca/laws/regulation/R01413" 413/01,  HYPERLINK "https://www.ontario.ca/laws/regulation/R02062" 62/02,  HYPERLINK "https://www.ontario.ca/laws/regulation/R02358" 358/02,  HYPERLINK "https://www.ontario.ca/laws/regulation/R04239" 239/04,  HYPERLINK "https://www.ontario.ca/laws/regulation/R04336" 336/04,  HYPERLINK "https://www.ontario.ca/laws/regulation/R05331" 331/05,  HYPERLINK "https://www.ontario.ca/laws/regulation/R06421" 421/06,  HYPERLINK "https://www.ontario.ca/laws/regulation/R07071" 71/07,  HYPERLINK "https://www.ontario.ca/laws/regulation/R07324" 324/07,  HYPERLINK "https://www.ontario.ca/laws/regulation/R07425" 425/07,  HYPERLINK "https://www.ontario.ca/laws/regulation/R08025" 25/08,  HYPERLINK "https://www.ontario.ca/laws/regulation/R08051" 51/08,  HYPERLINK "https://www.ontario.ca/laws/regulation/R08065" 65/08,  HYPERLINK "https://www.ontario.ca/laws/regulation/R08372" 372/08,  HYPERLINK "https://www.ontario.ca/laws/regulation/R08431" 431/08,  HYPERLINK "https://www.ontario.ca/laws/regulation/R08446" 446/08,  HYPERLINK "https://www.ontario.ca/laws/regulation/R11142" 142/11,  HYPERLINK "https://www.ontario.ca/laws/regulation/R11215" 215/11,  HYPERLINK "https://www.ontario.ca/laws/regulation/R13165" 165/13,  HYPERLINK "https://www.ontario.ca/laws/regulation/R14065" 65/14,  HYPERLINK "https://www.ontario.ca/laws/regulation/R15142" 142/15,  HYPERLINK "https://www.ontario.ca/laws/regulation/R15169" 169/15,  HYPERLINK "https://www.ontario.ca/laws/regulation/R15260" 260/15,  HYPERLINK "https://www.ontario.ca/laws/consolidated-regulations-change-notices" CTR 18 JL 17 - 3, HYPERLINK "https://www.ontario.ca/laws/regulation/r18145"145/18,  HYPERLINK "https://www.ontario.ca/laws/regulation/R19240" 240/19, HYPERLINK "https://www.ontario.ca/laws/regulation/R20061"61/20,  HYPERLINK "http://www.ontario.ca/laws/regulation/R20267" 267/20,  HYPERLINK "https://www.ontario.ca/laws/regulation/R20517" 517/20,  HYPERLINK "https://www.ontario.ca/laws/regulation/R20653" 653/20,  HYPERLINK "https://www.ontario.ca/laws/regulation/R21022" 22/21 (as am. by  HYPERLINK "https://www.ontario.ca/laws/regulation/R21158" 158/21),  HYPERLINK "https://www.ontario.ca/laws/regulation/R21158" 158/21. This is the English version of a bilingual regulation. 1.In this Regulation, COVID-19 point-of-care testing means testing that employs a COVID-19 medical device authorized by the Minister of Health (Canada) for point-of-care use; (analyse hors laboratoire visant dpister la COVID-19) fiscal year means the 12-month period beginning on April 1; (exercice) laboratory director means a person who is responsible for the administration of the scientific and technical operation of a laboratory including the supervision of tests and the reporting of the results of the tests; (directeur de laboratoire) laboratory supervisor means a person who under the general supervision of a laboratory director supervises laboratory personnel and who may perform tests requiring special scientific skills; (superviseur de laboratoire) laboratory technician means a person who under direct supervision performs laboratory tests which require limited technical skill and responsibilities; (technicien de laboratoire) laboratory technologist means a person who under general supervision performs tests which require the exercise of independent judgment; (technologiste de laboratoire) relevant means appropriate to the classes of tests for which the laboratory is licensed; (pertinent) spouse means, (a) a spouse as defined in section 1 of the Family Law Act, or (b) either of two persons who live together in a conjugal relationship outside marriage; (conjoint) technical director has the same meaning as laboratory supervisor. (directeur technique) R.R.O. 1990, Reg. 682, s.1; O.Reg. 352/98, s.1; O.Reg. 68/00, s.1; O.Reg. 331/05, s.1; O.Reg. 324/07, s.1; O. Reg. 653/20, s. 1; O. Reg. 158/21, s. 1. 2.The following classes of tests are prescribed for the purposes of the Act and this Regulation: 1. Bacteriology. 2. Virology. 3. Mycology. 4. Parasitology. 5. Immunology. 6. Serology HIV Antibody. 7. Hematology. 8. Biochemistry. 9. Cytology. 10. Immunoassays. 11. Histology (Pathology). 12. Immunohematology. 13. Cytogenetics. 14. Molecular Genetics. 15. Genetics. R.R.O. 1990, Reg. 682, s.2; O.Reg. 536/98, s.1; O.Reg. 239/04, s.1; O.Reg. 324/07, s.2. 3.(1)An application for a licence, or a provisional licence, to establish, operate or maintain a laboratory, or renewal thereof, shall be submitted to the Director. R.R.O. 1990, Reg. 682, s.3(1). (2)The fee for the issuance or renewal of a licence is $1,262 plus an additional $200 for each test that the licensee is authorized to perform under the licence that is not listed as a service in the schedule of laboratory benefits. O.Reg. 358/02, s.1. (3)The fee for the issuance or renewal of a provisional licence is $631 plus an additional $100 for each test that the licensee is authorized to perform under the licence that is not listed as a service in the schedule of laboratory benefits. O.Reg. 358/02, s.1. (3.1)In subsections (2) and (3), schedule of laboratory benefits means the schedule of laboratory benefits as defined in subsection 1 (1) of Regulation 552 of the Revised Regulations of Ontario, 1990 made under the Health Insurance Act. O.Reg. 17/01, s.1. (4)The operator of a licensed laboratory shall post the licence in a conspicuous place in the laboratory. R.R.O. 1990, Reg. 682, s.3(4). (5)The operator of a licensed laboratory shall post the accreditation certificate issued by the agency designated under section 14 in a conspicuous place in the laboratory. O.Reg. 25/08, s.1. 4.(1)A licence or renewal thereof that is issued to establish, operate or maintain a laboratory is subject to the following conditions: 1. That the operator and owner engage the services of a laboratory director. 2. That the operator and owner only engage the services of a person as laboratory director, laboratory supervisor, technical director, laboratory technologist or laboratory technician who meets the qualifications prescribed by section 6 or who is otherwise exempted under section 7. 3. That the management and operation of the laboratory is at the address set out in the licence for the laboratory. 4. That an Alphafetoprotein screen, HCG or Estriol, Inhibin or Pregnancy Associated Plasma Protein type A (PAPP-A) test or any combination of them not be performed if the person requesting the test indicates that the test is for a fetal assessment. 5. That a Hepatitis B surface antigen test not be performed if the person requesting the test indicates that the test is for a prenatal assessment. 6. That the Newborn Screening Test for amino acidopathies, fatty acid oxidation defects, organic acidemias, endocrinopathies, hemoglobinopathies, biotinidase, galactosemia, cystic fibrosis, severe combined immune deficiency, permanent hearing loss risk, mucopolysaccharidosis type I or spinal muscular atrophy not be performed if the person requesting the test indicates that the test is for newborn screening. 7. That the ColonCancerCheck FOBT not be performed. 8. That no payment or consideration of any kind be provided or offered to any donor of blood or blood constituents in return for the donation, whether directly or indirectly. 9. That no compensation for any expenditure of any kind or for time, travel or commitment be made to any donor of blood or blood constituents, whether directly or indirectly. R.R.O. 1990, Reg. 682, s.4; O. Reg. 399/93, s.1 (1); O.Reg. 239/04, s.2; O.Reg. 421/06, s.1 (1); O.Reg. 25/08, s.2; O.Reg. 51/08, s.1 (1); O. Reg. 165/13, s. 1; O. Reg. 65/14, s. 1; O. Reg. 240/19, s. 1; O. Reg. 267/20, s. 1. (2)A laboratory is exempt from the condition in paragraph 4 of subsection (1) if it is operated by any of the following: 1. Childrens Hospital Of Eastern Ontario Ottawa Childrens Treatment Centre. 2. Credit Valley Hospital. 3. North York General Hospital (General site). 4. Lakeridge Health Corporation (Oshawa site). 5. Sudbury Regional Hospital (St. Josephs Health Centre Site). 6. Mount Sinai Hospital. 7. London Health Sciences Centre (South Street Campus). O. Reg. 399/93, s.1(2); O.Reg. 564/00, s.1. (2.1)Revoked: O. Reg. 158/21, s. 2. (3)A laboratory is exempt from the condition in paragraph 5 of subsection (1) if it is operated by, (a) a public hospital; or (b) the Ontario Agency for Health Protection and Promotion. O.Reg. 446/08, s.1. (4)A laboratory operated by the Childrens Hospital Of Eastern Ontario Ottawa Childrens Treatment Centre is exempt from the condition in paragraph 6 of subsection (1). O.Reg. 421/06, s.1(2). (5)A laboratory is exempt from the condition in paragraph 7 of subsection (1) if it has entered into a Participation Agreement with the Ministry. O.Reg. 51/08, s.1 (2). (6)In subsection (5), Participation Agreement means an agreement between a laboratory and the Ministry under the Laboratory Services Funding Framework Agreement for the Colorectal Cancer Screening Program in which the laboratory agrees to conditions in respect of their participation in the program, including conditions that the laboratory will, (a) use the ColonCancerCheck FOBT kit for the purposes of the program, (b) distribute the ColonCancerCheck FOBT kits to, (i) legally qualified medical practitioners, (ii) registered nurses who hold an extended certificate of registration under the Nursing Act, 1991, and (iii) pharmacies, (c) provide the ColonCancerCheck FOBT kits to participants accessing the program through Telehealth Ontario, (d) report on the distribution and provision of the ColonCancerCheck FOBT kits under clauses (b) and (c) to Ontario Health for the purposes of the Ontario Cancer Screening Registry, and (e) participate in a quality assurance program that is designed for the program. O.Reg. 51/08, s.1 (2); O.Reg. 142/11, s.1; O. Reg. 61/20, s. 1. 4.1(1)No owner or operator of a laboratory shall, directly or indirectly, confer a benefit, or permit another person to confer a benefit on his or her behalf, on, (a) a health professional at whose request the laboratory examines specimens; (b) a member of the family of a health professional referred to in clause (a); or (c) a corporation that is owned or controlled by a health professional referred to in clause (a), by a member of the health professionals family or by another corporation that is owned or controlled by the health professional or a member of his or her family. O.Reg. 206/96, s.1. (2)For the purposes of subsection (1), an owner or operator of a laboratory confers a benefit on a person referred to in clause (1) (a), (b) or (c) by giving the person a gift, benefit or advantage of any kind, and, without limiting the generality of the foregoing, (a) by providing goods or services to the person at a cost that is less than the fair market value of the goods or services; (b) by paying all or part of the persons debts or financial obligations; (c) by lending the person money; or (d) by extending credit for goods and services to the person unless, (i) the credit is normally extended to persons in the ordinary course of business, (ii) the credit is extended under a written agreement that fixes the term for which the credit is extended and the rate of interest, and (iii) the term for which the credit is extended and the rate of interest at which the credit is extended are comparable to the terms and rates prevailing in the market at the time the credit is advanced. O.Reg. 206/96, s.1. (3)For the purposes of subsection (1), an owner or operator of a laboratory confers a benefit on a health professional referred to in clause (1)(a) by purchasing services from the health professional or paying a third party for services provided by the health professional unless, (a) the services are paid for under a written contract; (b) the services are of a kind ordinarily provided by the health professional; and (c) the amount paid for the services is not excessive having regard to the nature of the services. O.Reg. 206/96, s.1. (4)Despite subsections (1), (2) and (3), the owner or operator of a laboratory may employ the spouse or a member of the family of a health professional referred to in clause (1) (a), if the remuneration of the employee is reasonable given the nature of the employees duties, the amount of time for which the employee is paid and his or her performance at work. O.Reg. 206/96, s.1; O.Reg. 68/00, s.2; O.Reg. 331/05, s.2. (5)Despite subsections (1), (2) and (3), the owner or operator of a laboratory may provide supplies and equipment to a health professional referred to in clause (1) (a), with or without charge, if the supplies or equipment are to be used exclusively for the procurement or maintenance of specimens to be sent to the laboratory or for the reporting of the results of laboratory tests. O.Reg. 206/96, s.1. 4.2(1)No owner or operator of a laboratory shall enter into an agreement to rent premises to or from a person referred to in clause 4.1 (1) (a), (b) or (c), or permit another person to enter into such an agreement on his or her behalf, unless the amount of rent payable under the agreement is comparable to the amount of rent paid for similar premises in the same geographic area. O.Reg. 206/96, s.1. (2)No owner or operator of a laboratory shall enter into an agreement to rent premises to or from a person referred to in clause 4.1 (1) (a), (b) or (c), or permit another person to enter into such an agreement on his or her behalf, if the agreement provides for an amount of rent that varies in accordance with the number of services, or the monetary value of services, that are referred to the laboratory by the health professional referred to in clause 4.1 (1) (a), (b) or (c), as the case may be. O.Reg. 206/96, s.1. 4.3(1)Sections 4.1 and 4.2 do not apply if the benefit is conferred on, or the rental agreement provides that premises be rented to or from, (a) a health professional who holds at least a 50 per cent ownership interest in the laboratory or who is a member of the family of a person who holds at least a 50 per cent ownership interest in the laboratory; (b) a member of the family of a health professional who holds at least a 50 per cent ownership interest in the laboratory; (c) two or more health professionals who jointly hold at least a 50 per cent ownership interest in the laboratory; or (d) a corporation that is owned or controlled by a person referred to in clauses (a) or (b) or that is jointly owned or controlled by two or more health professionals referred to in clause (c). O.Reg. 206/96, s.1. (2)For the purposes of subsection (1), a person holds at least a 50 per cent ownership interest in a laboratory that is a corporation if the person holds 50 per cent or more of the issued shares of the corporation. O.Reg. 206/96, s.1. 4.4(1)In sections 4.1, 4.2 and 4.3, health professional means a member of a College of a health profession referred to in Schedule 1 of the Regulated Health Professions Act, 1991. O.Reg. 206/96, s.1. (2)For the purposes of sections 4.1, 4.2 and 4.3, a person is a member of another persons family if, (a) the person is the child or direct descendant of the other or is the brother or sister of the other; (b) the person is married to the other or to a person who is the child, the descendant, the brother or sister of the other; or (c) the person is the child of the brother or sister of the other. O.Reg. 206/96, s.1. (3)In subsection (2), child includes, with respect to any person, any other person with whom the person stands in the role of a parent. O.Reg. 206/96, s.1. 5.An applicant for a licence to establish, operate or maintain a laboratory shall, (a) have adequate laboratory staff who are qualified to perform the classes of tests for which the licence is sought; and (b) have equipment and premises that are suitable for the performance of the tests for which the licence is sought. R.R.O. 1990, Reg. 682, s.5. 6.(1)The qualifications for a laboratory director are that the person, (a) is a legally qualified medical practitioner who has been certified by the Royal College of Physicians and Surgeons of Canada in a branch of laboratory medicine; or (b) is a legally qualified medical practitioner who has two years of post-graduate training in a clinical laboratory or laboratories approved by the Director; or (c) has obtained from a university approved by the Director an academic doctorate degree with a relevant chemical, physical or biological science as a major subject and has two post-graduate years of laboratory training and experience in a laboratory or laboratories approved by the Director; or (d) has obtained from a university approved by the Director a masters degree with a relevant chemical, physical or biological science as a major subject and has five post-graduate years of laboratory training and experience in a laboratory or laboratories approved by the Director. R.R.O. 1990, Reg. 682, s.6 (1). (2)The qualifications for a laboratory supervisor or technical director are that the person, (a) is a legally qualified medical practitioner who has one post-graduate year of experience in a relevant laboratory specialty in a laboratory or laboratories approved by the Director; or (b) has obtained from a university approved by the Director an academic doctorate degree with a relevant chemical, physical or biological science as a major subject and has one post-graduate year of experience in a relevant laboratory specialty in a laboratory or laboratories approved by the Director; or (c) has obtained from a university approved by the Director a masters degree with a relevant chemical, physical or biological science as a major subject and has two post-graduate years of relevant laboratory training and experience in a laboratory or laboratories approved by the Director; or (d) has obtained from a university approved by the Director a bachelors degree with a relevant chemical, physical or biological science as a major subject and has a minimum of three post-graduate years of relevant laboratory training and experience of which at least two years shall have been in a laboratory or laboratories approved by the Director; or (e) is qualified as a laboratory technologist, and, (i) has at least six years of relevant laboratory experience approved by the Director, or (ii) has successfully completed relevant courses that together with experience are acceptable to the Director as equivalent to the experience referred to in subclause (i). R.R.O. 1990, Reg. 682, s.6 (2). (3)The qualifications for a laboratory technologist are that the person, (a) has obtained from a university approved by the Director a bachelors degree with a relevant chemical, physical or biological science as a major subject and has been employed for a minimum of one year as a laboratory technician in a laboratory approved by the Director; or (b) is recognized as a technologist by a technologist society in Canada, Great Britain or the United States, whose courses of study are approved by the Director; or (c) has obtained a diploma as a laboratory technologist from an Ontario Community College; or (d) has education or experience or both that is approved by the Director as equivalent to the standards prescribed in clause (a), (b) or (c). R.R.O. 1990, Reg. 682, s.6(3). (4)The qualifications for a laboratory technician are that the person, (a) has obtained an Ontario Secondary School Graduation Diploma or is able to produce evidence of equivalent standing that is approved by the Director and has served two years as a technical trainee in a laboratory approved by the Director; or (b) has obtained an Ontario Secondary School Graduation Diploma or is able to produce evidence of equivalent standing that is approved by the Director and has successfully completed relevant courses which together with experience are in the opinion of the Director equivalent to the standards prescribed in clause (a). R.R.O. 1990, Reg. 682, s.6(4). 7.Where a person is unable to meet the qualifications listed in section 6 for any particular category of employment, the person is exempted from the requirements of the said section in so far as they relate to that category of employment if he or she was employed in a laboratory on the 1st day of November, 1972, as a, (a) laboratory director; (b) laboratory supervisor or technical director; (c) laboratory technologist; or (d) laboratory technician, and has submitted evidence to the Director sufficient to satisfy the Director as to his or her competence and ability to adequately perform the duties of his or her office. R.R.O. 1990, Reg. 682, s.7. 8.(1)No laboratory director shall work or be employed as a laboratory director or laboratory supervisor in more than two laboratories unless the Director approves on the basis of need in the area or areas in which the laboratories are situated. R.R.O. 1990, Reg. 682, s.8 (1). (2)A laboratory supervisor shall not work or be employed as a laboratory supervisor in more than two laboratories unless the Director approves on the basis of need in the area or areas in which the laboratories are situated. R.R.O. 1990, Reg. 682, s.8(2). (3)Revoked: O. Reg. 158/21, s. 3. 9.(1)The owner and the operator of a laboratory shall ensure that the staff of the laboratory, (a) examine specimens from humans only, (i) at the request of a legally qualified medical practitioner or a dentist, (ii) at the request of a midwife, in respect of a test specified in Appendix B, (ii.1) at the request of a person who lawfully practises a health profession in a jurisdiction outside Ontario, if in that jurisdiction a laboratory may lawfully examine specimens at the request of that person, (iii) at the request of an insurer or an agent within the meaning of the Insurance Act, in respect of HIV Antibody testing, (iv) at the request of a registered nurse who holds an extended certificate of registration under the Nursing Act, 1991, (v) at the request of a person who is a participant in the provincial colorectal cancer screening program, in respect of a test or tests for the purposes of the program, (vi) at the request of a member of the College of Naturopaths of Ontario, in respect of a test specified in Appendix C, or (vii) at the request of a person registered as a pharmacist under the Pharmacy Act, 1991, in respect of a test for COVID-19; (a.1) report the results of tests performed as part of the provincial colorectal cancer screening program to Ontario Health for the purposes of the Ontario Cancer Screening Registry; (b) except in the case of a person described under subclause (a) (v), report the results of a test directly to the person who requested it and include in the report the name of the laboratory that received the specimen and the name and address of the laboratory in which the test was performed; (b.1) in the case of a person described under subclause (a) (v), report the results to Ontario Health for the purposes of the Ontario Cancer Screening Registry but not to the person; (c) report all positive laboratory findings that indicate the presumptive presence or presence of any disease of public health significance within the meaning of the Health Protection and Promotion Act to the medical officer of health of the health unit in which the person who gives rise to the case resides within 24 hours after the test is conducted, unless section 5.1 of Regulation 569 of the Revised Regulations of Ontario, 1990 (Reports) made under that Act applies; (d) establish a quality control program that is acceptable to the Director; (e) maintain such records and submit such reports as the Director may require and produce such records and reports as are considered necessary for purposes of this Regulation to the Director for inspection at all reasonable times; (f) analyze and report upon test samples submitted to the laboratory by the Director. R.R.O. 1990, Reg. 682, s.9; O.Reg. 795/93, s.1; O.Reg. 206/96, s.2(1); O.Reg. 46/98, s.1; O.Reg. 324/07, s.3; O.Reg. 65/08, s.1; O.Reg. 142/11, s.2; O.Reg. 215/11, s.1; O. Reg. 142/15, s. 1; O. Reg. 169/15, s. 1; O. Reg. 145/18, s. 1; O. Reg. 61/20, s. 2; O. Reg. 517/20, s. 1; O. Reg. 653/20, s. 4. (1.1)For the purposes of assisting staff of a laboratory to perform their duties in examining a specimen from an individual, the owner and the operator of the laboratory may collect personal health information about the individual indirectly from the person referred to in subclause (1) (a) (ii.1) or (iii) who makes the request for the examination. O.Reg. 336/04, s.1. (2)In this section, health profession means a health profession referred to in Schedule 1 to the Regulated Health Professions Act, 1991. O.Reg. 206/96, s.2(2). 10.The owner or operator of a laboratory may notify, (a) legally qualified medical practitioners; (b) laboratory owners or directors of licensed laboratories, or both; and (c) the Director, respecting the information set out in subsection 15 (1) of the Act. R.R.O. 1990, Reg. 682, s.10. 11.Laboratories operated by a ministry of the Crown in right of the Province of Ontario and every blood donor clinic of the Canadian Blood Services are exempt from the provisions of sections 5 to 16 of the Act and from the provisions of this Regulation. R.R.O. 1990, Reg. 682, s. 11; O. Reg. 239/04, s. 3, O. Reg. 169/15, s. 2. 12.All pharmacies and all pharmaceutical chemists employed in a pharmacy are exempt from the provisions of sections 5 to 16 of the Act and from the provisions of this Regulation with respect only to the performance of immunologic tests for pregnancy. R.R.O. 1990, Reg. 682, s. 12; O. Reg. 169/15, s. 2. 13.Every legally qualified medical practitioner who performs laboratory tests for the exclusive purpose of diagnosing or treating his or her own patients in the course of his or her medical practice is exempted from the provisions of sections 5 to 16 of the Act and from the provisions of this Regulation. R.R.O. 1990, Reg. 682, s. 13; O. Reg. 169/15, s. 2. 13.1Every member of the College of Naturopaths of Ontario who performs laboratory tests in his or her own office, in the course of his or her naturopathic practice, for the exclusive purposes of diagnosing or treating his or her own patients is exempted from the provisions of sections 5 to 16 of the Act and from the provisions of this Regulation with respect to the performance of the tests set out in Appendix D. O.Reg. 169/15, s. 3. 13.2A person who performs COVID-19 point-of-care testing is exempt from sections 5 to 16 of the Act and from the provisions of this Regulation. O. Reg. 158/21, s. 4. 13.3Revoked: O. Reg. 158/21, s. 4. 14.Institute for Quality Management in Healthcare is designated as an agency to carry out a quality management program. O.Reg. 260/15, s.1. 15.For the purposes of clause 9 (14) (c) of the Act, the fees set out in Column 2 of the Table to this section are prescribed for the classes of tests set out opposite those fees in Column 1. TABLE ItemColumn 1Column 21.Bacteriology$1,0552.Biochemistry1,3193.Cytogenetics7474.Cytology7475.Hematology1,1876.Immunoassays7377.Immuno-hematology9788.Immunology7559.Mycology87910.Parasitology1,03311.Histology (Pathology)65012.Serology HIV Antibody524O.Reg. 358/02, s.2; O.Reg. 239/04, s.4. Appendix A Revoked: O.Reg. 324/07, s.5. Appendix B Tests that a Midwife may Request 1. Bilirubin Total. 2. Bilirubin conjugated. 3. Glucose. 4. Urinalysis routine (includes microscopic). 5. Estriol. 6. HCG. 7. Hepatitis Associated Antigen or Antibody Immunoassay. 8. Newborn Screening Test for amino acidopathies, fatty acid oxidation defects, organic acidemias, endocrinopathies, hemoglobinopathies, biotinidase, galactosemia, cystic fibrosis, severe combined immune deficiency, permanent hearing loss risk, mucopolysaccharidosis type I or spinal muscular atrophy. 9. Alphafetoprotein Screen. 10. Albumin quantitative. 11. Serum Ferritin. 12. Serum Folate. 13.-16. Revoked: O.Reg. 71/07, s.1(1). 17. Sickle cell solubility test (screen). 18. Kleihauer. 19. Antibody Identification. 20. Antibody Screen. 21. Blood group ABO and Rho (D). 22. Blood group per antigen. 23. Direct Anti-human globulin test. 24. Cervicovaginal specimens. 25. Revoked: O.Reg. 71/07, s.1(1). 26. Chlamydia. 27. Culture cervical, vaginal (includes GC). 28. Culture other swabs or pus. 29. Culture urine. 30. Virus isolation. 31. Wet preparation (for fungus, trichomonas, parasites). 32. Strep B rapid screen. 33. Pregnancy Test. 34. Virus antibodies hemagglutination inhibition or ELISA technique (Rubella). 35. Non-cultural, indirect antibody or antigen assays by fluorescence, agglutination or ELISA technique (Toxoplasmosis). 36. Serology HIV Antibody. 37. VDRL. 38. Glucose tolerance test in pregnancy. 39. Revoked: O.Reg. 71/07, s.1(1). 40. Inhibin. 41. Pregnancy Associated Plasma Protein type A (PAPP-A). 42. Complete blood count (any method). 43. Smear only, Gram or Papanicolaou stain. O.Reg. 536/98, s.2; O.Reg. 239/04, s.5; O.Reg. 421/06, s.2; O.Reg. 71/07, s.1; O.Reg. 25/08, s.3; O. Reg. 165/13, s. 2; O. Reg. 240/19, s. 2; O. Reg. 267/20, s. 2. Appendix C Tests that a Naturopath may Request Tests Performed on Blood 1. 17-OH-Progesterone. 2. 5-dihydrotestosterone (DHT). 3. Adrenocorticotropic Hormone ACTH. 4. Alanine Transaminase (ALT, SGPT). 5. Albumin, qualitative. 6. Aldosterone. 7. Allergen Specific IgG Antibody. 8. Allergy testing (ELISA). 9. Allergy testing (IgE specific, RAST). 10. Alpha tocopherol Vitamin E. 11. Amino Acids Total Fractionation. 12. Ammonia. 13. Amylase. 14. Androstenedione. 15. Antibody Screening Food IgG. 16. Antibody Screening IgA. 17. Antibody Screening IgM. 18. Antigen Leukocyte Antibody. 19. Anti-Mllerian Hormone (AMH). 20. Anti-Nuclear Antibody. 21. Anti-Parietal Cell Antibody. 22. Anti-Reticulin Antibodies. 23. Apolipoprotein A1. 24. Apolipoprotein B. 25. Ascorbic Acid (ascorbate) Vitamin C. 26. Aspartate Transaminase. 27. Beta-Carotene (Carotene). 28. Bilirubin (total, total conjugated, unconjugated, direct and indirect). 29. Blood Group ABO and RhD. 30. Blood Urea Nitrogen (BUN). 31. Bun / Creatinine Ratio. 32. CA125. 33. CA15-3. 34. Calcium, Calcium ionized. 35. Candida Antibodies (IgM, IgG, IgA). 36. Carbon Dioxide Bicarbonate. 37. Carcinoembryonic Antigen. 38. Ceruloplasmin. 39. Chloride. 40. Cholinesterase, pseudo or true. 41. Coenzyme Q10. 42. Complement proteins C3 (B1C) and Complement proteins C4 (B1E). 43. Complete Blood Count. 44. Copper. 45. Cortisol bound and unbound, no differentiation. 46. C-peptide immunoreactivity. 47. C-Reactive Protein (CRP). 48. C-Reactive Protein High Sensitivity. 49. Creatine Phosphokinase. 50. Creatinine. 51. Creatinine Clearance. 52. Cystathionine. 53. Dehydroepiandrosterone sulphate (DHEAS). 54. Digitalis purpurea (digoxin). 55. Electrophoresis including total protein. 56. Endomysial Antibody. 57. Erythrocyte Sedimentation Rate (ESR) (Sedimentation Rate). 58. Estradiol. 59. Estriol. 60. Estrogen. 61. Estrone. 62. Fatty acids, free. 63. Ferritin. 64. Fibrinogen semi-quantitative and quantitative. 65. Folate. 66. FSH. 67. Galectin 3. 68. Gamma-glutamyl Transferase (GGT) / GG transpeptidase (GGTP). 69. Gliadin Antibodies (IgG, IgA). 70. Glomerular Filtration Rate (GFR). 71. Glucose-6-Phosphate Dehydrogenase (G-6-PD). 72. Glucose, quantitative. 73. Glucose Tolerance Test. 74. Glutathione. 75. Hemoglobin A1C. 76. Homocysteine. 77. Histocompatibility Testing HLA 27 typing. 78. Immunoglobulin (globulin). 79. Insulin, Fasting and Non-fasting. 80. Insulin-Like Growth Factor 1. 81. Intrinsic Factor Blocking Antibody. 82. Iron, total with iron binding capacity and per cent saturation. 83. Islet Cell Cytoplasmic Autoantibody. 84. Lactate dehydrogenase. 85. Lactate, Lactic Acid. 86. Lead. 87. Leptin. 88. Lipase. 89. Luteinizing Hormone. 90. Lyme Disease Antibodies. 91. Magnesium. 92. Memory Lymphocyte Immuno-Stimulation Assay (MELISA Test). 93. Mercury. 94. Mononuclear Heterophile Antibodies (Monospot). 95. Natriuretic Peptide Brain (BNP). 96. Parathyroid hormone. 97. PCB (polychlorinated biphenyls). 98. Phosphatase, alkaline. 99. Phosphorus (inorganic phosphate). 100. Potassium. 101. Pregnenolone. 102. Progesterone. 103. Prolactin. 104. Protein, Total (albumin / globulin ratio). 105. Prothrombin time and International Normalized Ratio (INR). 106. PSA, Ratio. 107. Reticulocyte count. 108. Retinol, Vitamin A. 109. Reverse T3. 110. Rheumatoid factor. 111. S-adenosylhomocysteine. 112. S-adenosyl methionine. 113. Sex Hormone Binding Globulin (SHBG). 114. Sodium. 115. Testosterone. 116. Testosterone, free. 117. Thyroglobulin. 118. Thyroid Peroxidase Antibody. 119. Thyroid Stimulating Immunoglobulin (TSI). 120. Thyroxine Free (FT4). 121. Total Cholesterol panel HDL / LDL / lipoprotein phenotyping (includes sample appearance, cholesterol, triglycerides, Lipopro VLDL cholesterol [calculated estimate]). 122. Trace Minerals. 123. Transferrin. 124. Transglutaminase IgA Antibody. 125. Trichlorobenzene. 126. Triiodothyronine Free (T3). 127. TSH (thyroid stimulating hormone). 128. Uric Acid (Urate). 129. Vitamin B (all tests). 130. Vitamin D 1,25-dihydroxy. 131. Vitamin D, 25-hydroxy. 132. Volatile solvents. 133. Zinc. Tests Performed on Stool 134. Bacteria / yeast (microbiology profile). 135. Calprotectin Fecal. 136. Comprehensive Digestive Stool Analysis. 137. Elastase. 138. Fecal Fat. 139. Occult Blood. 140. Parasites and Ova. Tests Performed on Urine 141. 5-dihydrotestosterone (DHT). 142. Aldosterone. 143. Bilirubin (total, total conjugated, unconjugated, direct and indirect). 144. Bisphenol A. 145. Calcium, Calcium ionized. 146. Chlorinated pesticides. 147. Cortisol bound and unbound, no differentiation. 148. Cortisol / Cortisone. 149. Creatinine Clearance. 150. Cultures urine, screening, actual culture without identification. 151. Dehydroepiandrosterone sulphate (DHEAS). 152. Estradiol. 153. Estriol. 154. Estrogen. 155. Estrone. 156. Human Growth Hormone. 157. Luteinizing Hormone. 158. Melatonin. 159. Oxytocin. 160. Porphyrins, screen. 161. Progesterone. 162. Routine Urinalysis (glucose, blood, ketone, leukocytes, etc.) 163. Testosterone. 164. Testosterone, free. 165. Thyroid hormones. 166. Toxic Metals. 167. Uric acid (urate). 168. Urinary Organic Acid Test. Tests Performed on Saliva 169. 17-OH-Progesterone. 170. 5-dihydrotestosterone (DHT). 171. Aldosterone. 172. Androstenedione. 173. Cortisol bound and unbound, no differentiation. 174. Dehydroepiandrosterone sulphate (DHEAS). 175. Esterol. 176. Estradiol. 177. Estriol. 178. Estrogen. 179. Estrone. 180. Melatonin. 181. Progesterone. 182. Testosterone. 183. Testosterone, free. Tests Performed on Hair 184. Heavy Metal hair element analysis. Tests Performed on Tissue/Discharge/Sputum 185. Culture throat swab for streptococcus screen only. 186. Culture and sensitivities (other swabs or pus culture and smear [includes screening]). 187. Culture and sensitivities (sputum culture and smear). 188. Nail and skin cultures. 189. Nasal swabs (other swabs or pus culture and smear [includes screening]). 190. Pap smear (smear only, gram or Papanicolaou stain as sole procedure). 191. Seminal fluid examination (complete). Tests Performed on Breath 192. Hydrogen breath test. 193. Intestinal permeability test. 194. Urea breath test for H. pylori. O. Reg. 169/15, s. 5. <=>?GHIJK* + , @ A B C D E F G H I J R S T Ʈ{{{{wjjhh0J+UhhZK5jh'9>*B*U\hmH phsH wh&h'9>*B*\hmH phsH wh/jh'9>*B*U\hmH phsH whh'9 h'95\ h5hh# hRE h^0J+jh^Uh^jh^U&IC UnDg3CM_mgdR1gdR1gdR1gd*gd*gdR1LgdZK gdSO*gd^T U   B C D E F G H I J K L M  ǺǺǺǺjhZKhZK0J+UjhZKhZK0J+UjhZKhZK0J+UhZKhZK0J+jhZKhZK0J+U hZKhZKhZKhh]jhh0J+Ujhh0J+Uhh0J+,     ! D E F G H I J K L \ ] ^ c d f g 0 1 2 8 9 ; < D E ҵҵҵ|ҵj h<h<0J+Ujh<h<0J+Uj:h<h<0J+Uh<h<0J+jh<h<0J+UjUhZKhZK0J+U hZKhZKhZKhZK0J+jhZKhZK0J+UjphZKhZK0J+U0E F G H I J K L w x y       D E F G H I J K L M S T V W j} h<h<0J+Uj h<h<0J+Uj h<h<0J+Uj h<h<0J+U hZKhZKjh<h<0J+Uj h<h<0J+Uh<h<0J+8  !&')*DEFGHIJKLefglmop9:;ABDٲ٢ْقjh<h<0J+Ujh<h<0J+Ujh<h<0J+Uj,h<h<0J+UjGh<h<0J+U hZKhZKh<h<0J+jh<h<0J+Ujbh<h<0J+U3DEFGHIJKLDEFGHIJKLUVW\]_`jTh<h<0J+Ujoh<h<0J+Ujh<h<0J+Ujh<h<0J+U hZKhZKjh<h<0J+Uh<h<0J+jh<h<0J+U7)*+1245DEFGHIJKLҺwjh|XhX0J+U hX0J+jh|XhX0J+Uh|XhFh hhZK0J+jh hUh hjh hUjh hh h0J+U hZKhZKj9h hh h0J+Uh hh h0J+jh hh h0J+U*$%&'(DEFHIJKLabchiklm²Ȯtkkkh&|h&|0J+jh&|h&|0J+Uh&|h?hH0J+h?h?0J+jh?Uh?jh?UhHjhFhO20J+U hO20J+jhFhO20J+UhO2jhFhF0J+UhFhF0J+jhFhF0J+U%3456<=?@AHIJz{|}ȿȿȫ|ssf]]]hhi0J+jhhi0J+Uhihi0J+h>1hi0J+jp h]h]0J+Uh]h]0J+jh]h]0J+Uh]jh3h30J+Uh3h30J+jh3h30J+Uh3h&|h&|0J+jh&|h&|0J+Ujh&|h&|0J+U $%3>?AIUVZfjmnǾ~z~zzzz~~~~z~~zh h8Th hR15hR1hh|XhZKmH sH h]j:"hh0J+Ujhh0J+Uhh0J+hih0J+hihi0J+hhi0J+jhhi0J+UjU!hhi0J+U.  ABCDI <@I <@Ig <@I  3<@CIabp~ hR10J,hR1h h@GTh]  0<@Iab456@ACIM_hlmwx{.456@ACIZhilwx45 hR15h*mH sH hgbmH sH hR1mH sH hR1Xm{.AZi ;!"""#m$g%gdR1gdR1gdR1#gdR1gdR156@ACIhlwx !456@ACIhlwx456@ACIhlwx{|  4 5 6 @ A C I h l w x !!4!5!6!;! hR10J, hR15 hR1NH hR1^JhR1Z;!@!A!C!I!h!l!w!x!!!!!!""""4"5"6"@"A"C"I"h"l"w"x""""""""##4#5#6#@#A#C#I#h#l#w#x#######$$4$5$6$@$A$C$I$h$l$m$w$x$$$$$$%%4%5%6%@%A%C%I%g%h%l%w%x%%%%%%%%&& hR1\ hR15hR1`g%%''}(-)***+2+b+++',N,,,$--../D0x00gdR1gdR1gdR1gdR1gd,gdR1#gdQogdR1& &4&5&6&@&A&C&I&h&l&w&x&&&&&&&&&&&''2'4'6'7'8'I'l'w'x'z'''''''''''(4(6(7(8(I(l(w(x(z(}((((((()-)4)6)7)8)I)l)w)x)z))))))))** ****4*6*I*L*M*N*htz h!Lhtzh7hR1 hR1\[N*l*w*x*******************+2+4+6+I+L+M+N+b+l+w+x++++++++++++&,',-,/,6,8,:,;,?,I,M,N,O,[,s,t,u,,,,,,,,,,,,,,$-.-/-G-I-[-s-t-u--------hV} hV}0J-hhl hlhlhR1Z-------../.I.[.s.t.u...............///I/[/s/t/u//////////////.0/0D0I0[0s0t0u0x0000000000000000 11#1.1/1I1[1s1t1u11111111111111112 hR10J,hR1`01#11L2233,4I5V667D777h8L9i:::q; =>S@bBBgdR1gdR1gdR1gdR1gdR1gdR12 2.2/2I2L2Q2[2s2u222222222222222222222.3/3=3I3[3s3u3v3333333333333333,4.4/4=4I4[4s4u4v44444444444444.5/5=5I5[5s5u5v55 hR15ht hM?hJ hM?ht hM?hg hM?hR1hR1hh;S5555555555555.6/6=6I6V6[6s6u6v6666666666666667.7/7=7D7I7[7s7u7v777777777777777.8/8=8I8[8h8s8u8v88888888888888.9/9=9I9L9[9s9u9v99999999999hR1d9999.:/:=:I:[:i:s:u:v::::::::::::::::.;/;=;I;[;q;s;u;v;;;;;;;;;;;;;;.</<=<I<[<s<u<v<<<<<<<<<<<<<< == =.=/===I=[=s=u=v==============.>h|XhR1mH sH hR1_.>/>=>I>[>s>u>v>>>>>>>>>>>>>>>>>.?/?=?I?[?s?u?v??????????????.@/@=@I@S@[@s@u@v@@@@@@@@@@@@@@.A/A=AIA[AsAuAvAAAAAAAAAAAAAA.B/B=BIB[BbBcBhBsBuBvB hR15hR1bvBBBBBBBBBBBBBBB.C/C=CIC[CsCuCvCCCCCCCCCCCCCCC.D/D=DFDID[DsDuDvDDDDDDDDDDDDDDD.E/E=EIE[EsEuEvEEEEEEEEEEEEEEE.F/F=FIF[FsFuFvFFFFFFFFFF hR15hR1bBCFDDEFFZGG,HHI!IIJ}JK\KLLMOoO-P`QRS TgdR1gdR1gdR1gdR1FFFFFFFFFG.G/G=GAGIGZG[GsGuGvGGGGGGGGGGGGGG,H.H/H=HIH[HsHuHvHHHHHHHHHHHHHHHI!I.I/I=III[IsIuIvIIIIIIIIIIIIIIIIIJ.J/J=JIJ[JsJuJvJ}JJJJJ hR15 hR10J,hR1_JJJJJJJJJJKKK.K/K=KIK[K\KsKuKvKKKKKKKKKKKKKKL.L/L=LIL[LsLuLvLLLLLLLLLLLLLLL.M/M=MIM[MsMuMvMMMMMMMMMMMMMMM.N/N=NIN[NsNuNvNNNNNNNNNNNN hR15hR1bNNNO.O/O=OIO[OoOsOuOvOOOOOOOOOOOOOO-P.P/P=PIP[PsPuPvPPPPPPPPPPPPPP.Q/Q=QIQ[Q`QsQuQvQQQQQQQQQQQQQQ.R/R=RIR[RsRuRvRRRRRRRRRRRRRRR.S/S=SIS[SsSuSvSShR1dSSSSSSSSSSSSS T.T/T=TIT[TsTuTvT{TTTTTTTTTTTTTT.U/U=UIUJU[UsUuUvUUUUUUUUUUUUUUU.V/V=VIV[VsVuVvVVVVVVVVVVVVVVV.W/W=WIWQW[WsWuWvWWWWWWWWWWWWhR1d T{TJUUVQWWaXXY[E\_\\\\]^__D`m`` aa]bb)gdR1gdR1gdR1gdR1gdR1WWWW.X/X=XIX[XaXsXuXvXXXXXXXXXXXXXXX.Y/Y=YIY[YsYuYvYYYYYYYYYYYYYYY.Z/Z=ZIZ[ZsZuZvZZZZZZZZZZZZZZ[[[.[/[=[I[[[s[u[v[[[[[[[[[[[[[[.\/\=\E\I\ hR15hR1bI\[\_\s\u\v\\\\\\\\\\\\\\\\\.]/]=]I][]s]u]v]]]]]]]]]]]]]]]]].^/^=^I^[^s^u^v^^^^^^^^^^^^^^^._/_=_I_[_s_u_v__________________hV} hV}0J-hb hR15hR1\____``````D`I`b`m```````````````aaaaa aaIabaaaaaaaaaaaaaabbbbbb*b7bGbIbJb]bbbbbbbbbbbbbbbbbbbbccccccIcbccch&|h(Q hR10J.; hR10J,hR1 hR15YcccccccccccccccccddEdIdWdid{d|d~dddddddddddddeeee3e4eIeaede~eeeeeeeeeeeeeffff4fIf\fafdf~fffffffffffffffgggghhbh~h&|0J,h&|h{hR1Wbcc|d4e\fghlBlDlIlWlalllllllllllllmm*m1m>mBmDmHmImWmammmmmmmmmmmmmmhM? hR10J,hH}hzdh_ 1hR hM?hRK` hM?hChChV)h(QhR1Ommmmmmnnn*n@nBnDnInWnannnnnnnnnnnnnnnooooo*oBoDoIoWoaooooooooooooooppppp#p$p*p3p4pBpDpIpLpMpNpSpWpappppppppppppppqqq*qBqDqIqWqh$qhh hR15hR1]Wqaqeqfqqqqqqqqqqqqqqqqqqrr*rBrDrIrWrar|r}rrrrrrrrrrrrrrrrrrrrrrrss*sBsDsIsWsassssssssssssstt*tBtDtItWtat h]YhzE!h]YhzE!5hzE!hsh#^ h]YhR1h]YhR15hR1hh$qPatttttttttttttu!u6u7u9u:u>uIuJuKuLuMuNuOuRuTu[u]u_u`udupurusutuyu|u}uuuuuuuuuuuuuuvľղh2qhs; hKchs;hqhs;5 hqhs; hR15\hR1hi hv hv0J- h]5\h5h]5\h] hn!hJS h?hJS hJS5\h?hJS5\hJShzE!6Musuvvvvvvvvvckd#$$If<4F H" Z0H    4 <a<yt= $IfgdigdR1gdR1gdv vvvv v v vvvvv&v0vIvlvovyv|v}vvvvvvvvvvvvvvvvvvw w wwwwwwwww%w)w*w-w/w6w:w;w>wIwOwPwSw`wdwewhwkwnwywzw|w}w~wwwwwwwwwwwwwwwwwwwwwwww hR15^J hR15hR1ht]vvvwwwoff $Ifgdikd#$$If<4F H" Z0H    4 <a<yt= $$Ifa$gdiwww%w)w{rrf $$Ifa$gdi $Ifgdikds$$$If<4F H" Z0H    4 <a<yt=)w*w-w6w:w{rrf $$Ifa$gdi $Ifgdikd%$$If<4F H" Z0H    4 <a<yt=:w;w>wIwOw{rrf $$Ifa$gdi $Ifgdikd%$$If<4F H" Z0H    4 <a<yt=OwPwSw`wdw{rrf $$Ifa$gdi $Ifgdikdh&$$If<4F H" Z0H    4 <a<yt=dwewhwzw~w{rrf $$Ifa$gdi $Ifgdikd'$$If<4F H" Z0H    4 <a<yt=~wwwww{rrf $$Ifa$gdi $Ifgdikd'$$If<4F H" Z0H    4 <a<yt=wwwww{rrf $$Ifa$gdi $Ifgdikd]($$If<4F H" Z0H    4 <a<yt=wwwww{rrf $$Ifa$gdi $Ifgdikd)$$If<4F H" Z0H    4 <a<yt=wwwww{rrf $$Ifa$gdi $Ifgdikd)$$If<4F H" Z0H    4 <a<yt=wwwww{rrf $$Ifa$gdi $Ifgdikd`*$$If<4F H" Z0H    4 <a<yt=wwwww x xxxxx%x/x0x7xIxPxkxnxyx|x}xxxxxxxxxxxxxxxyy y yyyyy%y/y=yAyIykynyyy|y}yyyyyyyyy z zzzzz1z3zIzNzjzkzlzmzhTD h!LhTD h1h.N hR10J.;hzE! hR10J- hR10J.hR1hR10J.;CJKww%xPx|xxxxxxy=y{vqlggggggggdR1gdTagdR1#gdR1kd+$$If<4F H" Z0H    4 <a<yt= =ylzzzzzz#{3{Q{g{{{{{|(|X|{|||||}d}}}~/~W~gdR1mzyzzzzzzzzzzzzzzz { {{{{#{/{3{H{I{J{Q{\{_{`{f{g{y{z{}{{{{{{{{{{{{{{{ | |||||(|/|H|I|J|X|\|_|`|f|y|{|||||||||||||||| } }}}}}/}H}I} hR10J.; hR10J-hR1h|XhR1mH sH ZI}J}N}\}_}`}d}f}y}}}}}}}}}}}}}}~~ ~ ~~~~/~4~;~H~I~J~W~\~_~`~e~f~y~~~~~~~~~~~~  /HIJ\_`fty hhhhtzh.Nhs hR10J-hR1 hR10J.;UW~e~~~~H6~)Q_m‚߂#gdQgdQgdQ#gdQogdR1FHJLbހ68:pv|~ ()*,1EPQRT^_`ablmopr|‚Ăłނ߂ h&hh h~h hh[ "#$&1>?@BE^`abcdr|كڃ܃݃ 1ETW^`bcefr|Ʉʄ̄̈́քׄل hh hfshh h~h[#?aڃcʄׄ@_s*a͆gdQلڄ  1@E^_`rstuv|  )*,-1789E^_`acdr|̆͆ΆІ hhh|XhmH sH h~hhZ͆*X{Ň#2@XgÈ)P̉'gdQ ()*,-/1EVWXZ[^`rz{|~ćŇLJȇ #$&(012@ACEWXY^`gr|h|XhmH sH hyvhmH sH  hhh h~hUˆÈĈƈ ()*,1EOPQ^`r|ˉ͉̉ω &'(*1EFGHJ]^`mnoqr| )*h|XhmH sH h&>hh h~hZ'Gn+GbmzϋPxԌ 4EvɍgdQ*+-.1EFGIJ^`abdelmopryz{|}‹΋ϋЋҋ 1EOPRS^`rwxz{|ӌԌՌ׌  !$1 h~hha13458DEHI^`ruvwyz|ȍɍ͍̍ '(1EF^`cdgr|Ɏʎ͎ΎЎݎގߎ 1246EM h&>hh h~h^ɍ(Fcʎߎ2N%JbƐ 9E^gdQgdQMNPR^`r| $%&)1EIJMN^`abefr|ÐŐƐǐʐ !$189:=DE^`abr| h&>hh|XhmH sH h~hhZ^ՑFxJf̔ +:VqgdQgdQԑՑّ֑4:DFbxdjpv !"CEHIJKNXYZ[^`efgjr| hh h&hh h~h[˔͔̔ΔД !)*+:;>CEFGMNUVWZ^`pqru|ĕ .028bdflĖ hYh hh h~hh[0d0dRϘ":e˙gdQgdQ.0dflpvޗ()*CPQRSVXϘӘ":;>CNOdeʙ˙͙ϙәٙܙ )*,.8;C\_g hh h&hh h~h[˙*hך#Oiϛ/<X<w<<<<<== =?=s=====gd #gd gd gdQghil֚ךؚۚ"#%';CNOikmΛϛ<.</<0<V<W<X<Y<Z<v<w<x<y<<<<<<<<<<<<<<<<<========== =!=#=>=?=A= hhUhozhL]h- h~h- h~hhVAppendix D Tests that a Naturopath may Perform 1. Ascorbic acid (ascorbate) Vitamin C. 2. Blood Group ABO and RhD. 3. BTA Bioterrain Assessment. 4. Fatty acids, free. 5. Glucose. 6. Hemoglobin A1C. 7. Human Chorionic Gonadotropin pregnancy test. 8. Indican. 9. Koenisberg. 10. Live blood cell analysis. 11. Mononuclear Heterophile Antibodies (monospot). 12. Oxidative testing. 13. Rapid Strep Test. 14. Routine urinalysis by dipstick. 15. Sulkowitch. 16. Vaginal pH. O. Reg. 169/15, s. 5.  HYPERLINK "http://www.ontario.ca/fr/lois/reglement/900682" Franais  HYPERLINK \l "Top" Back to top     PAGE 12 PAGE 13 A=B=V=Z=r=s=u=v===========================>>><>=>>>?>G>H>I>J>K>L>_>`>a>b>m>n>o>p>q>r>s>t>u>v>w>x>y>z>{>|>}>~>幵hSOhYIzhtjhtUj,h^U h^0J+j+h^Ujh^Uh^hozh)$LhL] h~hhD===>I>J>o>q>r>t>u>w>x>z>{>|>}>~>>>>>>>>>>&`#$gd^#gdQgdQ~>>>>>>>>>>>>>>>>>>>>>>>>h^hthYIzh4/h 0J mHnHu h4/0J jh4/0J UhSO>>>>>gd^? 000P1/ =!"#P$P% DpDyK yK vhttp://www.ontario.ca/fr/lois/reglement/900682yX;H,]ą'cDyK yK http://www.e-laws.gov.on.ca/navigation?file=currencyDates&lang=enDyK yK thttps://www.ontario.ca/laws/regulation/R21158yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R00068yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R00564yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R01017yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R01413yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R02062yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R02358yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R04239yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R04336yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R05331yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R06421yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R07071yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R07324yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R07425yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R08025yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R08051yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R08065yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R08372yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R08431yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R08446yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R11142yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R11215yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R13165yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R14065yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R15142yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R15169yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R15260yX;H,]ą'cDyK yK https://www.ontario.ca/laws/consolidated-regulations-change-noticesyX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/r18145yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R19240yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R20061yX;H,]ą'cDyK yK rhttp://www.ontario.ca/laws/regulation/R20267yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R20517yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R20653yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R21022yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R21158yX;H,]ą'cDyK yK thttps://www.ontario.ca/laws/regulation/R21158yX;H,]ą'c$$If<!vh#v#v" #vZ:V <40H,55" 5Z44 <a<yt=$$If<!vh#v#v" #vZ:V <40H55" 5Z44 <a<yt=$$If<!vh#v#v" #vZ:V <40H55" 5Z44 <a<yt=$$If<!vh#v#v" #vZ:V <40H55" 5Z44 <a<yt=$$If<!vh#v#v" #vZ:V <40H55" 5Z44 <a<yt=$$If<!vh#v#v" #vZ:V <40H55" 5Z44 <a<yt=$$If<!vh#v#v" #vZ:V <40H55" 5Z44 <a<yt=$$If<!vh#v#v" #vZ:V <40H55" 5Z44 <a<yt=$$If<!vh#v#v" #vZ:V <40H55" 5Z44 <a<yt=$$If<!vh#v#v" #vZ:V <40H55" 5Z44 <a<yt=$$If<!vh#v#v" #vZ:V <40H55" 5Z/ 44 <a<yt=$$If<!vh#v#v" #vZ:V <40H55" 5Z/ 44 <a<yt=$$If<!vh#v#v" #vZ:V <40H55" 5Z44 <a<yt=DyK yK vhttp://www.ontario.ca/fr/lois/reglement/900682yX;H,]ą'ciDyK Topx2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@66666_HmH nH sH tH 8`8 ^Normal_HmH sH tH ZZ  Heading 1$<@&5CJ KH OJQJ\^JaJ \\  Heading 2$<@& 56CJOJQJ\]^JaJVV  Heading 3$<@&5CJOJQJ\^JaJJJ  Heading 4$<@&5CJ\aJNN  Heading 5 <@&56CJ\]aJHH  Heading 6 <@&5CJ\aJBB  Heading 7 <@&CJaJHH  Heading 8 <@&6CJ]aJN N  Heading 9 <@&CJOJQJ^JaJDA D ^Default Paragraph FontVi@V  Table Normal :V 44 la (k (^No List j/j ^ amendednote-e $$ dB*$a$6_HhmH sH tH lol ^clause-e-$ d/o^`a$_HhmH sH tH 2o2 ^ defclause-epo"p ^ definition-e*$ Cd/o^`Ca$_HhmH sH tH 0o!20 ^ firstdef-eloBl ^ headingx-e#$$$ d/*$a$;CJ_HhmH sH tH roRr ^ paragraph-e-$ d/o^`a$_HhmH sH tH nobn ^ regnumber-e $$ @8d a$5;CJ_HhmH sH tH porp ^ regtitle-e#$$ @8d *$a$5;CJ_HhmH sH tH ^o^ ^ section-e$ d/da$_HhmH sH tH RoR ^ subclause-e! FE^`E4o4 ^ subsection-ePoP ^table-edC *$CJ_HhmH sH tH p/p ^tableheading-e#$$$ d*$a$;_HhmH sH tH ZoZ ^ version-e dB56_HhmH sH tH 4@4 Header  !4 `4 ^Footer  !.)`. ^ Page NumberHCH Body Text Indent!hx^hTN"T Body Text First Indent 2 "`\o2\ ^ footnote-e#$ d/oa$_HhmH sH tH d/Bd ^ paranoindt-e$$ d `a$_HhmH sH tH </ R< ^Notice %P 6B*ph@/Qb@ ^NoticeDisclaimer&[<^r< Normal (Web)'CJaJ*W * ^Strong5\0o0 ^ Ssection-e)dod ^ shorttitle-e *$$ dB*$a$5CJhmH sH 6U`6 Hyperlink >*B*ph,o, ^ovitalic60o0 ^ ovsmallcap:.o. ^ ovallcaps;</! < ^ parawindt2-e /-^-DTD Block Text0x]^2B2 Body Text1x<P"< Body Text 2 2dx>Q2> Body Text 33xCJaJPMBP Body Text First Indent 4`RRRR Body Text Indent 25dx^TSbT Body Text Indent 36x^CJaJ8"8 Caption 7xx5\2?2 Closing 8^B' B Comment ReferenceCJaJ44  Comment Text:$L$ Date;RYR  Document Map<-D M OJQJ^J<[< E-mail Signature=.X . Emphasis6]>* > Endnote ReferenceH*4+4  Endnote Text@p$p Envelope Address!A@ &+D/^@ CJOJQJ^JaJF%"F Envelope ReturnB OJQJ^JFV 1F FollowedHyperlink >*B* ph@& A@ Footnote ReferenceH*6R6  Footnote TextE0_a0 HTML Acronym:`r: HTML AddressG6]0a 0 HTML Cite6]:b : HTML CodeCJOJQJaJ<c < HTML Definition6]Bd B HTML KeyboardCJOJQJaJJeJ HTML PreformattedL OJQJ^J6f 6 HTML SampleOJQJFg F HTML TypewriterCJOJQJaJ8h 8 HTML Variable6]: : Index 1P8^`8: : Index 2Q8^`8: : Index 3RX8^X`8: : Index 4S 8^ `8:: Index 5T8^`8:: Index 6U8^`8:: Index 7Vx8^x`8:: Index 8W@8^@`8:: Index 9X8^`8H!H  Index HeadingY5OJQJ\^J.(. Line Number4/4 List[^`828 List 2\6^6`838 List 3]Q^Q`848 List 4^l^l`858 List 5_^`:0: List Bullet ` & F>6> List Bullet 2 a & F>7"> List Bullet 3 b & F>82> List Bullet 4 c & F>9B> List Bullet 5 d & F BDRB List Continueex^FEbF List Continue 2f6x^6FFrF List Continue 3gQx^QFGF List Continue 4hlx^lFHF List Continue 5ix^:1: List Number j & F>:> List Number 2 k & F>;> List Number 3 l & F ><> List Number 4 m & F>=> List Number 5 n & F l- l  Macro Text"o  ` @ OJQJ^J_HmH sH tH I Message Headergpn$d%d&d'd-DM NOPQ^n`CJOJQJ^JaJ>> Normal Indent q^4O4 Note Headingr<Z2< Plain Texts OJQJ^J0K0 Salutationt6@R6 Signature u^NJbN Subtitlev$<@&a$CJOJQJ^JaJT,T Table of Authoritiesw8^`8L#L Table of Figuresxp^`pV>V Titley$<@&a$5CJ KHOJQJ\^JaJ P.P  TOA Headingzx5CJOJQJ\^JaJ&& TOC 1{.. TOC 2 |^.. TOC 3 }^.. TOC 4 ~X^X.. TOC 5  ^ .. TOC 6 ^.. TOC 7 ^.. TOC 8 x^x.. TOC 9 @^@h/Bh ^assent-e$$$ d%.*$a$6CJ_HhmH sH tH 4/AR4 ^assent-fmH sH f/bf ^ chapter-e $$ d 5*$a$;CJ_HhmH sH tH 6/ar6 ^ chapter-fmH sH 4/4 ^clause-fmH sH :/: ^ defclause-fmH sH </!< ^ definition-fmH sH 8/Q8 ^defparagraph-e@/Q@ ^defparagraph-fmH sH 8o8 ^defsubclause-e@/@ ^defsubclause-fmH sH 4/ 4 ^ defsubpara-eN/Q N ^ subpara-e! EE^`E</  < ^ defsubpara-fmH sH >/1 " > ^defsubsubclause-eX/2 X ^subsubclause-e! #e^`eF/1 B F ^defsubsubclause-fmH sH :/a R : ^defsubsubpara-eT/Qb T ^ subsubpara-e! #e^`eB/a r B ^defsubsubpara-fmH sH \/ \ ^ ellipsis-e$ d/oa$_HhmH sH tH 8/ 8 ^ ellipsis-fmH sH d/ d ^ End Tumble-e$ d8x*$a$_HhmH sH tH </ < ^ End Tumble-fmH sH J/ J ^ equation-e$o*$a$ hmH sH 8/ 8 ^ equation-fmH sH 8/! 8 ^ firstdef-fmH sH lo l ^ heading1-e#$$$ d/*$a$:CJ_HhmH sH tH 8/  8 ^ heading1-fmH sH h/ h ^ heading2-e#$$$ d/*$a$:_HhmH sH tH 8/ " 8 ^ heading2-fmH sH f/2 f ^ heading3-e#$$$ d/*$a$_HhmH sH tH 8/1 B 8 ^ heading3-fmH sH 8/AR 8 ^ headingx-fmH sH Z/b Z ^insert-e$$dMa$56_HhmH sH tH 4/a r 4 ^insert-fmH sH X/ X ^line-e$ d/<<a$_HhmH sH tH 0/ 0 ^line-fmH sH n/ n ^ longtitle-e$$$ d *$a$5CJ_HhmH sH tH :/ : ^ longtitle-fmH sH n/ n ^ minnote-e'$ @ dC[a$6CJ_HhmH sH tH 6/ 6 ^ minnote-fmH sH b/ b ^number-e$ Hda$5CJ_HhmH sH tH 4/ 4 ^number-fmH sH :/Q : ^ paragraph-fmH sH </A < ^ paranoindt-fmH sH j/" j ^ parawindt-e%$ d `^a$_HhmH sH tH :/! 2 : ^ parawindt-fmH sH `/B ` ^ parawtab-e$ d `a$_HhmH sH tH 8/A R 8 ^ parawtab-fmH sH n/b n ^ partnum-e#$$$ d/*$a$5;CJ_HhmH sH tH 6/a r 6 ^ partnum-fmH sH 2/ 2 ^ Pclause-e56/ 6 ^ Pclause-fmH sH 6/ 6 ^ Pheading1-e5:/ : ^ Pheading1-fmH sH 6/ 6 ^ Pheading2-e5:/ : ^ Pheading2-fmH sH 6/1 6 ^ Pheading3-e5:/ : ^ Pheading3-fmH sH 6/A 6 ^ Pheadingx-e5:/  : ^ Pheadingx-fmH sH n/" n ^Pnote-e+$ dMd-DM &a$5CJ_HhmH sH tH 2/! 2 2 ^Pnote-fmH sH 8/QB 8 ^ Pparagraph-e5</A R < ^ Pparagraph-fmH sH \/b \ ^ preamble-e$ d/oa$_HhmH sH tH 8/a r 8 ^ preamble-fmH sH 4/ 4 ^ Psection-e58/ 8 ^ Psection-fmH sH 8/ 8 ^ Psubclause-e5</ < ^ Psubclause-fmH sH 4/ 4 ^ Psubpara-e58/ 8 ^ Psubpara-fmH sH :/ : ^ Psubsection-e5>/ > ^ Psubsection-fmH sH >/1  > ^Psubsubclause-e5B/  B ^Psubsubclause-fmH sH :/a " : ^ Psubsubpara-e5>/! 2 > ^ Psubsubpara-fmH sH D/Q B D ^Psubsubsubclause-e5^/R ^ ^subsubsubclause-e! ^`H/A b H ^Psubsubsubclause-fmH sH @/ r @ ^Psubsubsubpara-e5Z/Q Z ^subsubsubpara-e! ^`D/q D ^Psubsubsubpara-fmH sH L/ L ^ scanned-e $a$_HhmH sH tH 6/ 6 ^ scanned-fmH sH lo l ^ schedule-e'$$$ d/<*$a$;_HhmH sH tH 8/ 8 ^ schedule-fmH sH 6/ 6 ^ Sclause-e `6/ 6 ^ Sclause-fmH sH D/D ^ Sdefclause-e `</< ^ Sdefclause-fmH sH F/!"F ^ Sdefinition-e^`>/!2> ^ Sdefinition-fmH sH @/QB@ ^ Sdefpara-e `8/AR8 ^ Sdefpara-fmH sH 6/b6 ^ section-fmH sH </r< ^ shorttitle-fmH sH X/X ^note-e$ BdLa$_HhmH sH tH </Q< ^ Sparagraph-e `</< ^ Sparagraph-fmH sH 6/6 ^ SPsection-e5:/: ^ SPsection-fmH sH </< ^SPsubsection-e5@/@ ^SPsubsection-fmH sH 8/8 ^ Ssection-fmH sH </< ^ Ssubclause-e `</< ^ Ssubclause-fmH sH 8/ "8 ^ Ssubpara-e `8/!28 ^ Ssubpara-fmH sH 6/B6 ^ Ssubsection-e>/AR> ^ Ssubsection-fmH sH B/1 bB ^Ssubsubclause-e `B/arB ^Ssubsubclause-fmH sH >/a > ^ Ssubsubpara-e `>/> ^ Ssubsubpara-fmH sH h/h ^Start Tumble-e$ d8o*$a$_HhmH sH tH @/@ ^Start Tumble-fmH sH :/: ^ subclause-fmH sH 6/ 6 ^ subpara-fmH sH </< ^ subsection-fmH sH @/1 @ ^subsubclause-fmH sH </a < ^ subsubpara-fmH sH F/Q F ^subsubsubclause-fmH sH B/ "B ^subsubsubpara-fmH sH 2/22 ^table-fmH sH f/Bf ^toc-e$$$ d/,x*$a$5;CJ_HhmH sH tH ./AR. ^toc-fmH sH p/bp ^ tochead1-e'$$$ dCP(*$a$:CJ_HhmH sH tH 8/ar8 ^ tochead1-fmH sH D/ D ^ Yellipsis-e-DM b/b ^ xleftpara-e $ dMoa$CJ_HhmH sH tH :/: ^ xleftpara-f mH sH n/n ^xnum-e0 $ 0/dBo^/`a$CJ_HhmH sH tH :/: ^xnum-f  0/mH sH ^/^ ^xpara-e $ @dMZa$CJ_HhmH sH tH 2/2 ^xpara-fmH sH p/p ^ xpartnum-e#$$$ dM[*$a$5;CJ_HhmH sH tH 8/8 ^ xpartnum-fmH sH d/d ^xtitle-e $$ d*$a$;CJ_HhmH sH tH 4/"4 ^xtitle-fmH sH :/2: ^ Yellipsis-fmH sH J/QBJ ^Ypartheading-e-DM v/Rv ^ partheading-e#$$$ d/*$a$5;CJ_HhmH sH tH R/QbR ^Ypartheading-f-DM mH sH >/Qr> ^ partheading-fmH sH F/ F ^ YPheadingx-e-DM </< ^ YPheadingx-fmH sH >/> ^Ytable-e-DM 4/4 ^Ytable-fmH sH :/A: ^Ytoc-e-DM 0/0 ^Ytoc-fmH sH 8/18 ^ footnote-fmH sH h/h ^PrAssent#$ pda$6CJ_HhmH sH tH ^o^ ^ comment-e  pxx*$_HhmH sH tH l/l ^ Pheading-e#!$$$ d*$a$5CJ_HhmH sH tH 6/"6 ^ comment-f"mH sH @/2@ ^tableheading-f#mH sH HBH Yshorttitle-e$-DM L/a RL ^ Ypreamble-e% -DM B/a bB ^ Ypartnum-e&-DM D/ rD ^ Yheading1-e'-DM D/ D ^ Yheading2-e(-DM D/1 D ^ Yheading3-e)-DM L/L ^Ytableheading-e*-DM D/1D ^ Yfirstdef-e+-DM H/!H ^ Ydefinition-e,-DM F/F ^ Ydefclause-e--DM H/H ^ YSdefclause-e.-DM L/L ^Ydefsubclause-e/-DM R/! R ^Ydefsubsubclause-e0-DM L/L ^Ydefparagraph-e1-DM D/A"D ^ YSdefpara-e2-DM H/2H ^ Ydefsubpara-e3-DM N/Q BN ^Ydefsubsubpara-e4-DM B/RB ^ Ysection-e5-DM D/bD ^ YSsection-e6-DM H/rH ^ Ysubsection-e7-DM J/AJ ^YSsubsection-e8-DM @/@ ^ Yclause-e9-DM B/ B ^ YSclause-e:-DM F/F ^ Ysubclause-e;-DM H/H ^ YSsubclause-e<-DM L/1 L ^Ysubsubclause-e=-DM N/aN ^YSsubsubclause-e>-DM R/Q R ^Ysubsubsubclause-e?-DM F/QF ^ Yparagraph-e@-DM H/AH ^ Yparanoindt-eA-DM N/! "N ^ Yparawindt-eB-DM ^D/A 2D ^ Yparawtab-eC-DM H/BH ^ YSparagraph-eD-DM B/ RB ^ Ysubpara-eE-DM D/!bD ^ YSsubpara-eF-DM H/a rH ^ Ysubsubpara-eG-DM J/J ^YSsubsubpara-eH-DM N/ N ^Ysubsubsubpara-eI-DM D/ D ^ Yequation-eJ-DM H/H ^ YPsection-eK-DM 5F/F ^ YSPsection-eL-DM N/N ^YPsubsection-eM-DM 5L/L ^YSPsubsection-eN-DM F/F ^ YPclause-eO-DM 5L/L ^ YPsubclause-eP-DM 5R/1 R ^YPsubsubclause-eQ-DM 5X/Q "X ^YPsubsubsubclause-eR-DM 5L/Q2L ^ YPparagraph-eS-DM 5H/ BH ^ YPsubpara-eT-DM 5N/a RN ^YPsubsubpara-eU-DM 5T/ bT ^YPsubsubsubpara-eV-DM 5>Ar> Yshorttitle-fWmH sH :/Q: ^ Ypreamble-fXmH sH 8/a8 ^ Ypartnum-fYmH sH :/q: ^ Yheading1-fZmH sH :/: ^ Yheading2-f[mH sH :/: ^ Yheading3-f\mH sH B/B ^Ytableheading-f]mH sH :/: ^ Yfirstdef-f^mH sH >/> ^ Ydefinition-f_mH sH @/@ ^YSdefinition-f`mH sH J/!J ^YSdefinition-ea-DM </"< ^ Ydefclause-fbmH sH >/2> ^ YSdefclause-fcmH sH B/BB ^Ydefsubclause-fdmH sH H/RH ^Ydefsubsubclause-femH sH B/bB ^Ydefparagraph-ffmH sH :/!r: ^ YSdefpara-fgmH sH >/1> ^ Ydefsubpara-fhmH sH D/AD ^Ydefsubsubpara-fimH sH 8/Q8 ^ Ysection-fjmH sH :/a: ^ YSsection-fkmH sH >/q> ^ Ysubsection-flmH sH @/@ ^YSsubsection-fmmH sH 6/6 ^ Yclause-fnmH sH 8/8 ^ YSclause-fomH sH </< ^ Ysubclause-fpmH sH >/> ^ YSsubclause-fqmH sH B/"B ^Ysubsubclause-frmH sH D/2D ^YSsubsubclause-fsmH sH H/BH ^Ysubsubsubclause-ftmH sH </R< ^ Yparagraph-fumH sH >/b> ^ Yparanoindt-fvmH sH </!r< ^ Yparawindt-fwmH sH :/1: ^ Yparawtab-fxmH sH >/A> ^ YSparagraph-fymH sH 8/Q8 ^ Ysubpara-fzmH sH :/a: ^ YSsubpara-f{mH sH >/q> ^ Ysubsubpara-f|mH sH @/@ ^YSsubsubpara-f}mH sH D/D ^Ysubsubsubpara-f~mH sH :/: ^ Yequation-fmH sH :/: ^ YPsection-fmH sH </< ^ YSPsection-fmH sH @/"@ ^YPsubsection-fmH sH B/2B ^YSPsubsection-fmH sH 8/B8 ^ YPclause-fmH sH >/R> ^ YPsubclause-fmH sH D/bD ^YPsubsubclause-fmH sH J/!rJ ^YPsubsubsubclause-fmH sH >/1> ^ YPparagraph-fmH sH :/A: ^ YPsubpara-fmH sH @/Q@ ^YPsubsubpara-fmH sH F/aF ^YPsubsubsubpara-fmH sH 8/8 ^ Pheading-fmH sH 0/! 0 ^ defPnote-eZ/Z ^ headnote-e$ dLx*$5CJhmH sH 8/8 ^ headnote-fmH sH 8/! 8 ^ defPnote-fmH sH J/QJ ^Yprocsection-e ^@/"@ ^Yprocsection-fmH sH P/q2P ^Yprocsubsection-e ^F/1BF ^Yprocsubsection-fmH sH J/aRJ ^YprocSsection-e ^B/QbB ^YprocSsection-fmH sH H/rH ^YprocSsubsection-e ^H/qH ^YprocSsubsection-fmH sH N/N ^ Yprocclause-e  ^ >/> ^ Yprocclause-fmH sH T/T ^Yprocparagraph-e  ^ D/D ^Yprocparagraph-fmH sH T/T ^Yprocdefclause-e  ^ D/D ^Yprocdefclause-fmH sH N/N ^Yprocdefinition-eB^`BF/F ^Yprocdefinition-fmH sH Z/Z ^Yprocdefparagraph-e  ^ J/"J ^Yprocdefparagraph-fmH sH J/2J ^Yprocfirstdef-eB^`BB/1BB ^Yprocfirstdef-fmH sH @/R@ ^YprocSclause-e ^@/Qb@ ^YprocSclause-fmH sH F/rF ^YprocSdefclause-e ^F/QF ^YprocSdefclause-fmH sH H/H ^YprocSdefinition-e ^H/H ^YprocSdefinition-fmH sH B/!B ^YprocSdefpara-e ^B/B ^YprocSdefpara-fmH sH F/AF ^YprocSparagraph-e ^F/F ^YprocSparagraph-fmH sH b/b ^Yprocdefsubclause-e! F6^`J/J ^Yprocdefsubclause-fmH sH R/1R ^Yprocdefsubpara-e 6^F/"F ^Yprocdefsubpara-fmH sH h/2h ^Yprocdefsubsubclause-e! #`^``P/1BP ^Yprocdefsubsubclause-fmH sH X/ARX ^Yprocdefsubsubpara-e ^L/QbL ^Yprocdefsubsubpara-fmH sH F/rF ^YprocSsubclause-e ^F/qF ^YprocSsubclause-fmH sH B/QB ^YprocSsubpara-e ^B/B ^YprocSsubpara-fmH sH L/L ^YprocSsubsubclause-e ^L/L ^YprocSsubsubclause-fmH sH H/qH ^YprocSsubsubpara-e ^H/H ^YprocSsubsubpara-fmH sH T/T ^Yprocsubclause-e F6^D/D ^Yprocsubclause-fmH sH P/QP ^Yprocsubpara-e E6^@/"@ ^Yprocsubpara-fmH sH Z/2Z ^Yprocsubsubclause-e #^J/1BJ ^Yprocsubsubclause-fmH sH V/qRV ^Yprocsubsubpara-e #^F/QbF ^Yprocsubsubpara-fmH sH `/r` ^Yprocsubsubsubclause-e {^P/qP ^Yprocsubsubsubclause-fmH sH \/\ ^Yprocsubsubsubpara-e {^L/L ^Yprocsubsubsubpara-fmH sH </! < ^ YprocPnote-e ^</< ^ YprocPnote-fmH sH >/> ^ StatuteName:CJOJQJ:/: ^ StatuteChap CJOJQJN/N ^ StatuteHeader  `' aJmH sH H/H ^StatutePageNumCJOJQJmH sH Z/QZ ^procparagraph-edL-DM 5CJB/"B ^procparagraph-fmH sH T/2T ^ procclause-edL-DM 5CJ</1B< ^ procclause-fmH sH </R< ^TOCid-e>*B*phwh2/Qb2 ^TOCid-fmH sH V/rV ^TOCheadCenter-e$a$:>*B*phwhB/qB ^TOCheadCenter-fmH sH B/B ^ TOCtable-e>*B*phwh8/8 ^ TOCtable-fmH sH @/@ ^TOCschedCenter-e5D/D ^TOCpartCenter-e$a$5D/D ^TOCschedCenter-fmH sH B/B ^TOCpartCenter-fmH sH 2/2 ^issue-fmH sH T/T ^issue-e dBG_HhmH sH tH 8/ 8 ^transsection-e8/ "8 ^transsection-f>/ 2> ^transsubsection-e>/ B> ^transsubsection-f8/aR8 ^Yprocpartnum-e@/Qb@ ^Yprocpartnum-fmH sH D/QrD ^ NoticeAmend @ ^./Q. ^ SeeSource0/0 ^ Standard-e0/a0 ^ Standard-f0/a 0 ^ Ppartnum-e8/8 ^ Ppartnum-fmH sH Z/Z ^act-e $$ dB*$a$6_HhmH sH tH :/: ^ Yheadingx-fmH sH D/AD ^ Yheadingx-e-DM D/ D ^ Yschedule-e-DM :/: ^ Yschedule-fmH sH < "< Yline-e-DM 2!22 Yline-fmH sH ./B. ^act-fmH sH >/R> ^ amendednote-fmH sH b/bb ^ commiss-e $$ dB*$a$:_HhmH sH tH \/r\ ^form-e $$ dB*$a$;_HhmH sH tH 0/q0 ^form-fmH sH FaF Yregnumber-e-DM << Yregnumber-fmH sH :/a: ^ regnumber-fmH sH 8/q8 ^ regtitle-fmH sH V/V ^ruleb-e dB*$5_HhmH sH tH 2/2 ^ruleb-fmH sH `/` ^rulec-e$ dB*$a$5;_HhmH sH tH 2/ 2 ^rulec-fmH sH Z/ Z ^rulei-e dB*$56_HhmH sH tH 2/ " 2 ^rulei-fmH sH Z/2 Z ^rulel-e dB*$5;_HhmH sH tH 2/1 B 2 ^rulel-fmH sH 2/q+R 2 ^ signature-e./+b . ^ signtit-eb/r b ^ subject-e $$ dB*$a$;_HhmH sH tH 6/q 6 ^ subject-fmH sH / ^ tocpartnum-e' $$$ dMx(*$a$%5;CJOJQJ_HhmH sH tH B/ B ^ Yminnote-e -DM 6/ 6 ^ version-f mH sH d/ d ^ ActTitle-e $$ d*$a$5;CJhmH sH F/ F ^ regaction-e $$*$a$mH sH 8/ 8 ^ ActTitle-fmH sH :/ : ^ regaction-fmH sH X/!X ^dated-e$ dB!_HhmH sH tH 2/!!2 ^dated-fmH sH D/1!"!D ^made/app/filed-fmH sH /2! ^made/app/filed-et$$ \8p P!%0*h.26;H?CGK(P`TX\a@eximq vXzdBxa$_HhmH sH tH F/qB!F ^ regtitleold-e5CJOJQJ>/A!R!> ^ regtitleold-fmH sH 2/+b!2 ^ signature-f./+r!. ^ signtit-f6/a!6 ^ commiss-fmH sH :/!: ^Yact-e-DM 0/!!0 ^Yact-fmH sH </q!< ^Yform-e-DM 2/!!2 ^Yform-fmH sH @/!@ ^note-f B/mH sH 8/ !8 ^ Yminnote-fmH sH D/q!D ^ Yregtitle-e-DM :/!": ^ Yregtitle-f mH sH >/"> ^Yruleb-e!-DM 4/"""4 ^Yruleb-f"mH sH >/1 2"> ^Yrulel-e#-DM 4/1"B"4 ^Yrulel-f$mH sH >/R"> ^Yrulec-e%-DM 4/Q"b"4 ^Yrulec-f&mH sH >/ r"> ^Yrulei-e'-DM 4/q""4 ^Yrulei-f(mH sH B/q "B ^ Ysubject-e)-DM 8/""8 ^ Ysubject-f*mH sH D/"D ^ Yheadnote-e+-DM :/"": ^ Yheadnote-f,mH sH 6/""6 ^ TOChead-f-mH sH @/"@ ^ TOChead-e.>*B*phwh(/"( ^ovbold5./#. ^ ovregular56/#6 ^ ovitalicbold56X/"#X ^ tablelevel1-e#2 hhdB^h`>/!#2#> ^ tablelevel1-f3mH sH X/B#X ^ tablelevel2-e#4 XXdB^X`>/A#R#> ^ tablelevel2-f5mH sH X/b#X ^ tablelevel3-e#6 HHdB^H`>/a#r#> ^ tablelevel3-f7mH sH X/#X ^ tablelevel4-e#8 88dB^8`>/##> ^ tablelevel4-f9mH sH F/#F ^tablelevel1x-e:hdB^h@/##@ ^tablelevel1x-f;mH sH F/#F ^tablelevel2x-e<XdB^X@/##@ ^tablelevel2x-f=mH sH F/#F ^tablelevel3x-e>HdB^H@/##@ ^tablelevel3x-f?mH sH </! $< ^ parawindt3-e @C^C@/q&$@ ^equationind1-fAmH sH 8/ "$8 ^equationind2-eB@/!$2$@ ^equationind2-fCmH sH 8/a B$8 ^equationind3-eD@/A$R$@ ^equationind3-fEmH sH 8/ b$8 ^equationind4-eF@/a$r$@ ^equationind4-fGmH sH F/$F ^tablelevel4x-eH8dB^8@/$$@ ^tablelevel4x-fImH sH >/$> ^ headnoteind-e J^>/$$> ^ headnoteind-fKmH sH >o1$> ^footnoteLeft-eL$a$@/$$@ ^footnoteLeft-fMmH sH :/$: ^ TOCpartLeft-eN5>/$$> ^ TOCpartLeft-fOmH sH </%< ^ UnderBlue>*B*phwh</$%< ^TOCschedLeft-eQ5@/%"%@ ^TOCschedLeft-fRmH sH </q2%< ^ TOCheadLeft-eS$a$>/1%B%> ^ TOCheadLeft-fTmH sH D/1R%D ^ Yfootnote-eU-DM D/b%D ^ Yfootnote-fV-DM L/$r%L ^Yfootnoteleft-eW-DM L/$%L ^Yfootnoteleft-fX-DM 6/%%6 ^ TOCpart-fYmH sH D/%D ^ TOCpart-eZ5>*B*phwh8/%%8 ^ TOCsched-f[mH sH B/%B ^ TOCsched-e\>*B*phwh</ %< ^ tocpartnum-f]mH sH B/a %B ^partnumRevoked-e^5;D/%%D ^partnumRevoked-f_mH sH 8/&8 ^ ovboldallcaps5;Bo &B ^scheduleRevoked-ea;F/&"&F ^scheduleRevoked-fbmH sH :/q2&: ^ formRevoked-ec;>/1&B&> ^ formRevoked-fdmH sH R/R&R ^ OLCheadere (`'d`1$_HmH sH tH V/b&V ^ OLCfooterf$ (`'F1$a$_HmH sH tH 8/Qr&8 ^equationind1-egJ/!#&J ^Ytablelevel1-eh-DM @/&&@ ^Ytablelevel1-fimH sH L/#&L ^Ytablelevel1x-ej-DM B/&&B ^Ytablelevel1x-fkmH sH J/A#&J ^Ytablelevel2-el-DM @/&&@ ^Ytablelevel2-fmmH sH L/#&L ^Ytablelevel2x-en-DM B/&&B ^Ytablelevel2x-fomH sH J/a#'J ^Ytablelevel3-ep-DM @/''@ ^Ytablelevel3-fqmH sH L/#"'L ^Ytablelevel3x-er-DM B/!'2'B ^Ytablelevel3x-fsmH sH J/#B'J ^Ytablelevel4-et-DM @/A'R'@ ^Ytablelevel4-fumH sH L/$b'L ^Ytablelevel4x-ev-DM B/a'r'B ^Ytablelevel4x-fwmH sH :/': ^sdefsubclause-exB/''B ^sdefsubclause-fymH sH N/''N ^Ysdefsubclause-ez-DM D/''D ^Ysdefsubclause-f{mH sH </'< ^ parawindt2-f|mH sH </$'< ^ parawindt3-f}mH sH B/'B ^tableheadingrev-e~;2o '2 ^ heading1x-e2/ (2 ^ heading1x-f:/%(: ^partnumRepeal-e:/%"(: ^partnumRepeal-f</&2(< ^scheduleRepeal-e</!&B(< ^scheduleRepeal-f4/1&R(4 ^ formRepeal-e4/A&b(4 ^ formRepeal-fD/'r(D ^tableheadingRepeal-eD/((D ^tableheadingRepeal-fF/'(F ^tableheadingrev-fmH sH d/(d ^subsubsubsubclause-e! ii^i`L/((L ^subsubsubsubclause-fmH sH F/(F ^ xnumsub-eH@]H^`@*/a(* ^CautionL/q&(L ^Yequationind1-e-DM L/$(L ^Yequationind1-f-DM L/!$)L ^Yequationind2-e-DM L/1$)L ^Yequationind2-f-DM L/A$")L ^Yequationind3-e-DM L/Q$2)L ^Yequationind3-f-DM L/a$B)L ^Yequationind4-e-DM L/q$R)L ^Yequationind4-f-DM N/(b)N ^ xnumsub-f 0H]mH sH F/'r)F ^ Yheading1x-e-DM </q))< ^ Yheading1x-fmH sH T/)T ^Yprocheadnote-e-DM ^T/)T ^Yprocheadnote-f-DM ^:/): ^ tableitalic-e6:/1): ^ tableitalic-f6J/))J ^Ytableitalic-e-DM J/))J ^Ytableitalic-f-DM 6/)6 ^ tablebold-e56/1*6 ^ tablebold-f58/*8 ^ Ytablebold-e58/"*8 ^ Ytablebold-f52/2*2 ^bhnote-ed/@/1*B*@ ^bhnote-f B mH sH D/Q R*D ^defsubsubsubclause-eD/b*D ^defsubsubsubclause-fF/r*F ^Ydefsubsubsubclause-eF/A*F ^Ydefsubsubsubclause-fN/q*N ^Yprocdefsubsubsubclause-eN/*N ^Yprocdefsubsubsubclause-fB/q*B ^Yprocheading1-e ^B/**B ^Yprocheading1-fmH sH H/#*H ^tableitaliclevel1x-e6H/#*H ^tableitaliclevel1x-f6B/)*B ^tablebolditalic-e5B/)+B ^tablebolditalic-f5@/+@ ^headnoteitalic-e6H/"+H ^headnoteitalic-f 6mH sH 6/2+6 ^ xheadnote-e5>/B+> ^ xheadnote-f 5mH sH 6/ R+6 ^ Pschedule-e5>/ b+> ^ Pschedule-f 5mH sH `/r+` ^ rsignature-e $$ dB1*$a$:hmH sH `/+` ^ rsignature-f $$ dB1*$a$:hmH sH Z/+Z ^ lsignature-e$ dB1*$:hmH sH Z/+Z ^ lsignature-f$ dB1*$:hmH sH \/+\ ^ rsigntit-e $$ dB*$a$6hmH sH \/+\ ^ rsigntit-f $$ dB*$a$6hmH sH V/+V ^ lsigntit-e$ dB*$6hmH sH V/+V ^ lsigntit-f$ dB*$6hmH sH n/+n ^Notice-e#$ @ dCPa$ B*CJ_HhmH phsH tH ./!,. ^ certify-e./!,. ^ certify-fF/ ",F ^ YPheading3-e-DM F/ 2,F ^ YPheading3-f-DM J/&B,J ^Yproctablelevel1x-e ^J/&R,J ^Yproctablelevel1x-f ^N/A,b,N ^Yproctableboldlevel1x-e5N/Q,r,N ^Yproctableboldlevel1x-f5to,t ^ConsolidationPeriod-edBZ1$ B*CJ\_HmH phsH tH F/+,F ^NoticeAmend1-e$^a$L/+,L ^NoticeAmend2-e$dL^a$8/,,8 ^NoticeAmend3-eN/+,N ^ NoticeProc1-e$dLx^a$N/,,N ^ConsolidationPeriod-fmH sH 4/+,4 ^Notice-fmH sH @/,,@ ^NoticeAmend1-fmH sH @/,-@ ^NoticeAmend2-fmH sH @/,-@ ^NoticeAmend3-fmH sH >/,"-> ^ NoticeProc1-fmH sH H/2-H ^ Yparawindt2-e-DM H/'B-H ^ Yparawindt2-f-DM H/$R-H ^ Yparawindt3-e-DM H/'b-H ^ Yparawindt3-f-DM 2/ r-2 ^ heading2x-e2/! -2 ^ heading2x-f2/A -2 ^ heading3x-f2/1 -2 ^ heading3x-eX/A-X ^Yprocparanoindt-e-DM ^F/--F ^Yprocparanoindt-fmH sH 6/-6 ^ pnoteclause-e6/-6 ^ pnoteclause-fJ/$-J ^YTOCpartLeft-e-DM @/-.@ ^YTOCpartLeft-fmH sH >/Q.> ^YTOCid-e-DM 4/.".4 ^YTOCid-fmH sH D/%2.D ^ YTOCSched-e-DM :/1.B.: ^ YTOCSched-fmH sH D/R.D ^ YTOCTable-e-DM :/Q.b.: ^ YTOCTable-fmH sH J/1%r.J ^YTOCheadLeft-e-DM @/q..@ ^YTOCheadLeft-fmH sH N/.N ^YTOCPartCenter-e-DM D/..D ^YTOCPartCenter-fmH sH N/q.N ^YTOCHeadCenter-e-DM D/..D ^YTOCHeadCenter-fmH sH B/".B ^ YTOCHead-e-DM 8/..8 ^ YTOCHead-fmH sH ./".. ^ TOCForm-e6/./6 ^ TOCForm-fmH sH B/./B ^ YTOCForm-e-DM 8//"/8 ^ YTOCForm-fmH sH X/1/X a Pnote-e Char'5CJfHhmH q &sH tH HB/H cx Balloon TextCJOJQJ^JaJZ/Q/Z cxBalloon Text Char CJOJQJ^JaJmH sH tH p/b/p FConsolidationPerioddBZ1$ B*CJ\_HmH phsH tH F/q/F :zE!Comment Text Char mH sH tH Rv!/R F0Unresolved MentionB*ph`^\q PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭Vj\{cp/IDg6wZ0s=Dĵw %;r,qlEآyDQ"Q,=c8B,!gxMD&铁M./SAe^QשF½|SˌDإbj|E7C<bʼNpr8fnߧFrI.{1fVԅ$21(t}kJV1/ ÚQL×07#]fVIhcMZ6/Hߏ bW`Gv Ts'BCt!LQ#JxݴyJ] C:= ċ(tRQ;^e1/-/A_Y)^6(p[_&N}njzb\->;nVb*.7p]M|MMM# ud9c47=iV7̪~㦓ødfÕ 5j z'^9J{rJЃ3Ax| FU9…i3Q/B)LʾRPx)04N O'> agYeHj*kblC=hPW!alfpX OAXl:XVZbr Zy4Sw3?WӊhPxzSq]y H ,.03T  E D5;!&N*-259.>vBFJNSWI\_cgkmWqatvwmzI}ل*1MgA=~>>NPQRSTUVWXYZ\]_`acdefgijklnopqstuvwymg%0B TbMuvw)w:wOwdw~wwwwww=yW~#͆'ɍ^˙=>>O[^bhmrxz{|}~>G+@SCIL ]cf18;x LSV &)flo:ADV\_* 1 4  $ ' b h k 5 < ? |   #,/FRX4XXTXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXTXXXXTXTXTX4XT%(3!!@ @H 0(  0(  B S  ?TopTOCBK1U PpU Pp#e$e%e&e'e(e)e*e+e,e-e.e/e0e 1e2e3e4e5e6e""""T#T##########))OOO     ""##Z#Z##########))OOO 9*urn:schemas-microsoft-com:office:smarttagsState9*urn:schemas-microsoft-com:office:smarttagsplace8*urn:schemas-microsoft-com:office:smarttagsCity:*urn:schemas-microsoft-com:office:smarttagsStreet;*urn:schemas-microsoft-com:office:smarttagsaddress=*urn:schemas-microsoft-com:office:smarttags PlaceName=*urn:schemas-microsoft-com:office:smarttags PlaceType +?GHI4 k  # $ * - 5 UZ*6^g6#?# ((X(h(4)D))))b0booyoAqHqbqnqqqqqprr(s1sxx|{{+|2|E|U|V|]|d|q|||||||||g~o~~~ivрۀEMˆ҆  !)WZdnMUʒ͒$,-/GRSTVWYZ\]_`dor}I4 k Tdor}KCR4 k   V m D &$M$**WWi\i\cceelsmnoX~STVWYZ\]_`dKBCR4 i  m D 2""&$M$**WW[[[|\3]3]__cceelsmnnqjrkrlrwwSTVWWYZ\]_`d |Hn}+~r_lȡ:g*2d9Y:|f:4(;fl=o> ?S?/ @ J@;`@RB\CUDDTDREvG3H{=I.K|0K4MKlvK L)$LK4L MN.N6NSOP_P(Q\QJST%0U1h;&YAT)Jt|]b ?uRiS2qzgY67##\+@ROBr VGj JQH>H{QzdM?jU^>xiV);<>t7&>ZK%Z c [2At3 d?FR` ix" dX=)rRjryJvJyTV@dxy@@(@0@x@Unknown G.[x Times New Roman5Symbol3. .[x Arial3.[x Times5..[`)Tahoma?= .Cx Courier NeweAx Times New (W1)Times New RomanC.,.{$ Calibri Light7..{$ CalibriA$BCambria Math#@h#"n6GbW}K W}K d ~2qX ?I2! xx JP:\Wdocs\OLC Word Environment\Publication\Style Catalogue\10pt_catalog.dotOLaboratory and Specimen Collection Centre Licensing Act - R.R.O. 1990, Reg. 682 LABORATORIES8         Oh+'0k$0<T `l    PLaboratory and Specimen Collection Centre Licensing Act - R.R.O. 1990, Reg. 682LABORATORIES10pt_catalog98Microsoft Office Word@犥@@@"/E@!LW}GiVT$m" 4   !1."System- "SystemP,F%Hd,-"System--@Times New Roman---  2 <P0    0''  2 P0    0''  2 1  2   '''--- 2 VP0 Franais  2 V~0   @Times New Roman---  2 g0 L   2 g0 a [2 g50 boratory and Specimen Collection Centre Licensing Act               2 gh0    0''@Times New Roman---@Times New Roman--------- 42 20 R.R.O. 1990, REGULATION 682     ---  2 0    0''--- 2 c 0 LABORATORIES    2 0    0''@Times New Roman---@Times New Roman------------ +2 P0 Consolidation Period: ---  2 0   2 0 From   2 0 March 3, 2021   2 '0   2 *0 to the   2 H0 e  2 M0 - &2 Q0 Laws currency date   2 0 .  2 0  @Times New Roman---- @ !fH-  ---  2 P0 L  2 X0 a  2 _0 s  2 d0 t  2 h0    2 j0 a  2 q0 m  2 |0 endment:   2 0   2 0 158/21  2 0 .  2 0    0''  2 P0 Legislative Hi  2 0 story:  2 0 404/ 2 S0 91, 607/91, 525/92, 399/93, 417/93, 795/93, 206/96, 46/98, 352/98, 536/98, 551/99,   2 0 6  2 0 8  2 0 /  2 0 0  2 0 0  2 0 ,  2 0   2 0 564/00 2 0 ,   0'' 2 P0 17/01 2 p0 ,  2 u0 413/01 2 0 ,  2 0 62/02 2 0 ,  2 0 358/ 2 0 02 2 0 ,  2 0 239/04 2 0 ,  2 0 336/04 2 E0 ,  2 J0 331/05 2 q0 ,  2 v0 421/06 2 0 ,  2 0 71/07 2 0 ,  2 0 324/07 2 0 ,  2 0 425/07 2 0 ,  2 0 25/08 2 >0 ,  2 C0 51/08 2 c0 ,  2 h0 65/08 2 0 ,  2 0 372/08 2 0 ,  2 0 431/08 2 0 ,   0'' 2 "P0 446/08 2 "w0 ,  2 "~0 142/1  2 "0 1 2 "0 ,  2 "0 215/11 2 "0 ,  2 "0 165/13 2 "0 ,  2 "0 65/14 2 "(0 ,  2 "/0 142/15 2 "V0 ,  2 "\0 169/15 2 "0 ,  2 "0 260/15 2 "0 ,  2 " 0 CTR 18 JL 17    2 "0 -  2 " 0    2 " 0 3  2 "0 ,  2 "0   2 "0 145/18 2 "@0 ,  2 "F0 240/19  2 "m0 ,  2 "p0   2 "s0 61/20 2 "0 ,  2 "0 267 2 "0 /20 2 "0 ,  2 "0 517/20 2 "0 ,   0'' 2 0P0 653/20 2 0w0 ,  2 0|0 22/21  2 00   2 00 (as am.   2 00 by  2 00 158/21  2 00 )  2 00 ,  2 00   2 00 158/21  2 0/0 .  2 020    0''@Times New Roman--- 2 FP0 This i  2 Fp0 s  2 Fu0   2 Fx 0 the English v  2 F 0 ersion of a  2 F0   2 F0 bi 2 F 0 lingual  2 F4 0 regulation.  2 Fq0    0''---@Times New Roman- - - ---- - - ---  2 [P0  - - -  2 []0 1. 2 [g0  --- 2 [n 0 In this Regu  2 [0 lati 2 [0 on,  2 [0    0'' 2 pP0 COVID    2 p0 - 2 p0 19 point  2 p0 - 2 p0 of  2 p0 - 2 p 0 care test 2 p0 ing 2 p0  means   2 p90 testing  2 p\0   2 pa0 that  2 pw0   2 p|0 employs   2 p0 a COVID    2 p0 - 52 p0 19 medical device authorized   2 p0   #2 p0 by the Minister   2 p0 of   0'' "2 ~]0 Health (Canada)    2 ~0   2 ~ 0 for point  2 ~0 - 2 ~0 of  2 ~0 - 2 ~0 care u 2 ~0 se  2 ~&0 ;  2 ~*0    2 ~-0 (  2 ~10  X2 ~730 analyse hors laboratoire visant dpister la COVID    2 ~J0 - 2 ~N0 19  2 ~\0   2 ~b0 )  2 ~f0    0'' 2 P0 fisc +2 i0 al year means the 12   2 0 - I2 )0 month period beginning on April 1; (exer   2 0 cice  2 0 )  2 0    0'' +2 P0 laboratory director  2 0   &2 0 means a person who    2 80    2 <0 i 22 ?0 s responsible for the admi   2 0 n  2 0 i C2 %0 stration of the scientific and techni  2 0 c  2 0 al operation o 2 0 f a   0'' 2 ]0 laborat  2 0 o 2 0 ry  2 0   A2 $0 including the supervision of tests a 2 R0 nd t 2 f 0 he report g2 =0 ing of the results of the tests; (directeur de laboratoire)  2 0    0''  2 P0  2 V0 labor  2 r0 a ,2 y0 tory supervisor means   2 0   &2 0 a person who under   2 o0    2 t0 t 22 x0 he general supervision of   2 0 a  2 0   C2 %0 laboratory director supervises labora  2 0 t 2 0 ory   0'' 2 ] 0 personnel  2  0 and who may    2 0   2 0 pe C2 %0 rform tests requiring special scienti  2 0 fic  2  0 skills; ( 72 0 superviseur de laboratoire)  2 }0    0'' =2 P!0 laboratory technician means a p  2 0 erson  2 70   ,2 =0 who under direct super  (2 0 vision performs lab  2 .0 or 22 90 atory tests which require    2 0 l  2 0 i 2 0 mited   0'' :2 ]0 technical skill and responsibil  2 0 i  2 0 ties; (techni 2 D 0 cien de lab  2 0 o 2 0 ra 2 0 toire)  2 0    0'' 72 P0 laboratory technologist mea  2 0 ns a  2 0   2 0 person w  j2 M?0 ho under general supervision performs tests which require the e   2 0 xerci  2 0 s 2 0 e of   0'' %2 ]0 independent judgm  (2 0 ent; (technologist 2 '0 e  #2 00 de laboratoire)  2 0    0'' 2 5P 0 relevant  2 50   2 50   Y2 540 means appropriate to the classes of tests for which   2 5 0 the laborat  2 50 o 2 50 ry  2 50   2 50 is lic 2 50 en &2 5 0 sed; (pertinent)  2 5j0    0'' 2 KP 0 spouse  2 K0 mean  2 K0 s,  2 K0    0''@Times New Roman- - - ---- - - ---  2 `P0   2 `]0 (a)  2 `l0    2 `t0 a  2 `{0   .2 `}0 spouse as defined in se  2 `0 c  2 `0 tion 1 of the - - -   2 `B0 Family Law Act  --- 2 `0 , or  2 `0    0''  2 uP0   2 u]0 (b)  2 ul0   2 ut0 eithe  2 u0 r  2 u0   +2 u0 of two persons who li   R2 u/0 ve together in a conjugal relationship outside   2 u0 m   2 u0 a )2 u0 rriage; (conjoint)  2 ut0    0'' :2 P0 technical director has the sa 2  0 me meaning    2 >0 a 2 E0 s  2 N0 labora 2 w0 to #2 0 ry supervisor.  2  0 (directeur  2 0 tech 2 ) 0 nique)  /2 Y0 R.R.O. 1990, Reg. 682, s      2 0 .  2 0   2 0 1;   0'' 2 ]0 O.   2 i0   "2 l0 Reg. 352/98, s.   2 0   2 0 1; O.   2 0   2  0 Reg. 68/0  2 0 0, s.  2 *0   2 -0 1; O.   2 H0   "2 K0 Reg. 331/05, s.   2 0   2 0 1; O.   2 0   "2 0 Reg. 324/07, s.   2 0    2 0 1 ,2 0 ; O. Reg. 653/20, s. 1   +2 0 ; O. Reg. 158/21, s.     0''  2 ]0 1  2 d0 .  2 g0    0''- - - ---- - - ---  2 P0  - - -  2 ]0 2. 2 g0  --- %2 n0 The following cla   2 0 s  2 0 s X2 30 es of tests are prescribed for the purposes of the   2 0 A   2 0 c 2  0 t and this  2 0   2 0 Re  2 ,0 gulati 2 J0 on:  2 \0    0''  2 P0   2 b0 1.  2 l0   2 t 0 Bacteriology.   2 0    0''  2 P0   2 b0 2.  2 l0   2 t0 Virol  2 0 ogy.  2 0    0''  2 P0   2 b0 3.  2 l0   2 t0 Mycolo   2 0 g 2 0 y.  2 0    0''  2 P0   2 b0 4.  2 l0   2 t 0 Parasitology.  2 0    0''  2 &P0   2 &b0 5.  2 &l0   2 &t 0 Immunology.   2 &0    0''  2 ;P0   2 ;b0 6.  2 ;l0   (2 ;t0 Serology HIV Antibo    2 ;0 dy.  2 ;0    0''  2 PP0    2 Pb0 7  2 Pi0 .  2 Pl0   2 Pt 0 Hematology.    2 P0    0''  2 fP0   2 fb0 8.  2 fl0   2 ft0 Bioc  2 f 0 hemistry.   2 f0    0''  2 {P0   2 {b0 9.  2 {l0   2 {t 0 Cytology.   2 {0    0''  2 P0   2 [0 10.  2 l0   2 t 0 Immunoassays.   2 0    0''  2 P0   2 [0 11.  2 l0    2 t0 H  +2 ~0 istology (Pathology).  2 0    0''  2 P0   2 [0 12.  2 l0   %2 t0 Immunohematology.    2 0    0''  2 P0   2 [0 13.  2 l0    2 t0 C   2 }0 y  2 0 t 2  0 ogenetics.  2 0    0'' "System,Hd, !._f, ,0!- -   00//.. ՜.+,D՜.+,\x  < K  PLaboratory and Specimen Collection Centre Licensing Act - R.R.O. 1990, Reg. 682 Title8T\   _PID_HLINKS From DateTo Date8MSIP_Label_034a106e-6316-442c-ad35-738afd673d2b_Enabled7MSIP_Label_034a106e-6316-442c-ad35-738afd673d2b_SiteId6MSIP_Label_034a106e-6316-442c-ad35-738afd673d2b_Owner8MSIP_Label_034a106e-6316-442c-ad35-738afd673d2b_SetDate 5MSIP_Label_034a106e-6316-442c-ad35-738afd673d2b_Name <MSIP_Label_034a106e-6316-442c-ad35-738afd673d2b_Application EMSIP_Label_034a106e-6316-442c-ad35-738afd673d2b_Extended_MSFT_Method SensitivityAtoxTop|(u/http://www.ontario.ca/fr/lois/reglement/900682VUr.https://www.ontario.ca/laws/regulation/R21158VUo.https://www.ontario.ca/laws/regulation/R21158WRl.https://www.ontario.ca/laws/regulation/R21022QTi.https://www.ontario.ca/laws/regulation/R20653RPf.https://www.ontario.ca/laws/regulation/R20517O c-http://www.ontario.ca/laws/regulation/R20267WW`.https://www.ontario.ca/laws/regulation/R20061V\].https://www.ontario.ca/laws/regulation/R19240U]Z.https://www.ontario.ca/laws/regulation/r18145{kWDhttps://www.ontario.ca/laws/consolidated-regulations-change-noticesVRT.https://www.ontario.ca/laws/regulation/R15260URQ.https://www.ontario.ca/laws/regulation/R15169UPN.https://www.ontario.ca/laws/regulation/R15142TSK.https://www.ontario.ca/laws/regulation/R14065UTH.https://www.ontario.ca/laws/regulation/R13165VQE.https://www.ontario.ca/laws/regulation/R11215UTB.https://www.ontario.ca/laws/regulation/R11142Q]?.https://www.ontario.ca/laws/regulation/R08446QZ<.https://www.ontario.ca/laws/regulation/R08431V^9.https://www.ontario.ca/laws/regulation/R08372U_6.https://www.ontario.ca/laws/regulation/R08065U\3.https://www.ontario.ca/laws/regulation/R08051U[0.https://www.ontario.ca/laws/regulation/R08025QT-.https://www.ontario.ca/laws/regulation/R07425VT*.https://www.ontario.ca/laws/regulation/R07324UQ'.https://www.ontario.ca/laws/regulation/R07071QU$.https://www.ontario.ca/laws/regulation/R06421VW!.https://www.ontario.ca/laws/regulation/R05331VV.https://www.ontario.ca/laws/regulation/R04336WV.https://www.ontario.ca/laws/regulation/R04239VV.https://www.ontario.ca/laws/regulation/R02358UU.https://www.ontario.ca/laws/regulation/R02062QQ.https://www.ontario.ca/laws/regulation/R01413UQ.https://www.ontario.ca/laws/regulation/R01017PW .https://www.ontario.ca/laws/regulation/R00564UW .https://www.ontario.ca/laws/regulation/R00068VU.https://www.ontario.ca/laws/regulation/R21158BBhttp://www.e-laws.gov.on.ca/navigation?file=currencyDates&lang=en|(/http://www.ontario.ca/fr/lois/reglement/900682 20210303Present OPS - Unclassified Informationion Protection OPS - Unclassified Informationclassified Information- Unclassified Informationmatic OPS - Unclassified InformationAutomatic OPS - Unclassified Informationmatic OPS - Unclassified InformationAutomatic OPS - Unclassified Information  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@BCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvxyz{|}~Root Entry F t&_Data  -1TableWordDocumentAHSummaryInformation(AkDocumentSummaryInformation8wlCompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q